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ABSTRACT 
Staphylococcus aureus is one of the most common causes of bovine intramammary infections 
and mastitis in modern dairies worldwide and the most common mastitis pathogen isolated 
from raw milk. S. aureus is easily transmissible and infections caused by S. aureus respond 
poorly to treatment. The economic losses due to S. aureus mastitis are considerable, and 
include decrease in milk production, reduced milk quality through contamination by bacteria 
and increased milk SCC, veterinary and treatment costs, premature culling of cows and loss of 
genetic potential. Mastitis caused by S. aureus also adversely affects welfare of dairy cows. 
 
This thesis focuses on determination of the prevalence of S. aureus IMIs in Finland (I), 
investigating the antimicrobial resistance of S. aureus isolated from IMIs (I), in particular 
resistance against penicillin and methicillin (II-IV), and on studying the relationship between 
S. aureus strain-types and distribution (II-III), clinical severity (II-III), persistence (II-III), and 
transmission and reservoirs of intramammary infections (IV).  
 
Study I represents the results of a third nationwide mastitis survey conducted in 2001 in 
randomly selected Finnish dairy herds. S. aureus was isolated from 430 (3.4%) of the 12 661 
quarters of 334 (10.2%) of the 3282 cows sampled, and from 140 (64.8%) of the 216 herds 
included in the survey. The results indicate that S. aureus remains a significant mastitis 
pathogen in Finland as both the prevalence of quarters and the prevalence of cows infected by 
S. aureus has remained nearly stable. The proportion of S. aureus representing a mastitis-
causing agent decreased from the previous survey of 1995, but the total number of quarters 
that were positive for bacterial growth significantly increased. 
 
Compared with the previous surveys, the proportion of penicillin resistant, β-lactamase 
producing S. aureus remained almost stabile but was still high, approximately 50%. In almost 
half of the survey herds (study I), penicillin resistant S. aureus were isolated and were 
distributed throughout dairy herds and persisted for long periods, as shown in study IV. 
 
In studies II-III, clinical data and bacterial isolates from field cases of S. aureus mastitis were 
collected in the practice area of the Ambulatory Clinic, Faculty of Veterinary Medicine. The 
isolates were typed using PFGE and a selection of different virulence determinants and those 
encoding penicillin and methicillin resistance were identified with PCR. Among the diverse 
number of pulsotypes identified with PFGE typing, strains of five pulsotypes dominated as 
the cause of S. aureus mastitis. One pulsotype was associated with more severe signs and a 
more acute local response, as determined by milk NAGase activity, but was almost always 
eliminated from the mammary gland. There were numerous different gene profiles. The genes 
encoding haemolysins and LukED leukocidin were ubiquitous, whereas those for SAgs were 
more or less pulsotype-linked. At least one SAg-encoding gene was present in the majority of 
the predominant pulsotypes. Multiple genes for SAgs existed in combinations, which suggests 
that they are located in genetic clusters or pathogenicity islands. The mecA gene for oxacillin 
(methicillin) resistance was not detected. 
 
S. aureus strains that had the enterotoxin-encoding genes sed and sej were overrepresented in 
persistent mastitis. sed and sej permanently co-existed with the penicillin-resistance gene 
blaZ, suggesting the presence of a penicillinase plasmid in these strains. Within strains of 
pulsotype A, which typically harboured sed, sej, and blaZ, those positive for sed, sej, and blaZ 
persisted significantly more compared with the strains containing blaZ only. This suggests 
 8 
that among penicillin-resistant blaZ positive strains, a subgroup of strains containing sed and 
sej may be more likely linked with chronic mastitis than the other subgroups. 
 
S. aureus isolates in study IV were derived from cases of mastitis during one year and those 
collected from extramammary sites (teat skin, teat canals and skin lesions, milking liners, 
hands and nostrils of the milking personnel) at one farm visit from two dairy herds with 
different management regimes. Selected isolates were subjected to PFGE typing and PCR 
analysis for genes coding for virulence and adhesion factors. Nine PFGE types were found, 
the two herds each having their own predominant type and sharing one type. The predominant 
types were present in all sites studied in both herds, suggesting that the extramammary sites 
can be important reservoirs for intramammary infections and mastitis, or that the strains 
infecting the mammary gland can spread to body sites and in the environment. In both herds, 
strains of the predominant pulsotypes contained adhesion genes fnbA, and fnbB, whereas only 
fnbA was detected in strains of the other pulsotypes. This could indicate that strains with 
fnbA, and fnbB exhibit higher adhesion capacity and consequently have an advantage over the 
other strains in the herds. 
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1. INTRODUCTION 
Staphylococcus aureus is commonly resident on skin and mucous membranes of cattle. 
Despite its generally benign nature, in changing circumstances, as response to damage and 
exposure of structures below the epithelial or mucosal surface, S. aureus can behave as a 
pathogen. The induction of intramammary infection requires production of a variety of 
virulence factors enabling adherence, colonisation, invasion of the mammary cells of the 
bovine host by the S. aureus cells, evasion of the immune defence mechanism and survival in 
the host environment. The possession of virulence factors, which seems to be always 
increasing, varies among different S. aureus strains. 
 
Some S. aureus strains are better adapted to infect the bovine mammary gland, whereas others 
are less important as a cause of mastitis. Many factors, including the use of antimicrobials, 
management of the herd, and general and individual characteristics of the host, create 
continuous selective pressure on S. aureus strains. Beyond this pressure, genetic material is 
exchanged between the strains, and those strains better adapted to survive are selected. During 
this evolutionary process S. aureus strains that are more virulent or more resistant to 
antimicrobials are likely to develop. Identification of these strains is possible using the tools 
of molecular microbiology. 
 
Abundant evidence is available that virulence of S. aureus strains varies. Despite the 
fundamental and widely used measures to control and prevent S. aureus mastitis, this 
microorganism can cause herd-wide outbreaks and persist for long periods. It seems likely 
that the currently employed control measures are limited regarding prevention and control of 
the spread of particular S. aureus strains. 
 
The focus of this thesis was on characterisation of S. aureus mastitis in Finland. Prevalence, 
antibiotic resistance and epidemiology of intramammary infections caused by S. aureus were 
studied. Isolates from bovine IMI were investigated to determine whether differences in 
clinical significance exist between strains and to establish if certain strain types or 
determinants for virulence can be specifically linked with mastitis. The information presented 
in this thesis will be useful for planning more efficient strategies to control and prevent S. 
aureus mastitis. 
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2. REVIEW OF THE LITERATURE 
Infections caused by Staphylococcus aureus (S. aureus) were characterised first by Sir 
Alexander Ogston, a Scottish surgeon, more than one hundred years ago. In 1890 S. aureus 
was reported to cause mastitis in cattle. S. aureus is a gram-positive, catalase-positive, usually 
oxidase-negative, facultative anaerobic coccus, which belongs to the family of 
Micrococcaceae and the group of staphylococci. S. aureus can be distinguished from other 
staphylococcal species on the basis of gold colony pigmentation, production of coagulase, 
fermentation of mannitol and trehalose, and production of heat stable thermonuclease. 
 
Most S. aureus isolates are enclosed in a polysaccharide capsule, which can be categorised 
into eleven different serotypes. Beneath the capsule there is a cell wall with a thick and highly 
cross-linked peptidoglycan layer and teichoic acid, which is typical of gram-positive bacteria 
(van Wely et al., 2001). The surface proteins of S. aureus share a common overall structure 
and are involved in binding to fibrinogen, fibronectin, collagen and IgG. Penicillin-binding 
proteins, PBP1-4, produced by S. aureus are involved in the cell wall peptidoglycan 
assembly. These proteins are able to bind to beta-lactam antibiotics. 
 
The universal features of S. aureus genome are circular 2800 kilo base pair chromosome, one 
or more plasmids, prophages, transposons, insertion sequences and other incompletely 
characterised accessory genetic elements (Projan and Novick, 1997). To date, more than 10 
complete S. aureus genomes have been sequenced. The core genome of S. aureus, which 
includes the housekeeping genes essential for cell growth and division, is relatively 
conserved. Up to 20% of S. aureus chromosomes consist of mobile genetic elements, which 
are defined DNA segments that can replicate on their own. The major types of these elements 
include plasmids, S. aureus pathogenicity islands, bacteriophages, insertion sequences, and 
staphylococcal cassette chromosomes. Since many of these elements encode virulence or 
antimicrobial resistance genes, transfer of these segments into and out of S. aureus strains can 
affect the strain pathogenicity. The distributions of mobile genetic elements vary markedly 
between S. aureus strains and even within same strain lineages (Holden and Lindsay, 2008). 
2.1 Epidemiology and characteristics of bovine Staphylococcus aureus intramammary 
infection 
2.1.1 Prevalence and significance 
S. aureus is one of the most frequently isolated pathogens in bovine IMI worldwide 
(Aarestrup et al., 1995a; Myllys et al., 1994a; Myllys et al., 1998; Acuna et al., 2001; Chaves 
et al., 2001; Gianneechini et al., 2002; Barrett et al., 2005; Tenhagen et al., 2006) and the 
most common contagious mastitis pathogen isolated from raw milk (Piccinini et al., 2003b; 
Olde Riekerink et al., 2006). 
 
Studies from about 25 years ago estimated that 100% of the dairy herds in California 
(Gonzalez et al., 1988), 48% in Vermont (Goldberg et al., 1991) and 93% in Great Britain 
(Wilson and Richards, 1980) included cows infected with S. aureus. The proportion of cows 
with S. aureus IMI has been approximately 21% in Great Britain (Wilson and Richards, 
1980), 11% in Norway (Bakken, 1981), 10% in Denmark, (Aarestrup et al., 1995b), 10% in 
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Finland (Myllys et al., 1998), 9% in California (Gonzalez et al., 1988) and 5% in Vermont, 
USA (Goldberg, 1991; Hogan, 1997). 
 
Long-term surveys suggest that the significance of S. aureus in the dairy industry has 
remained unchanged (Sol, 2002; Swinkels et al., 2005). S. aureus IMI causes economic losses 
in several ways: decrease in milk production, reduced milk quality brought about by bacterial 
contamination and increased milk SCC, veterinary and treatment costs, requirement for 
premature culling and loss of genetic potential (Østerås et al., 2005; Hogeveen and Østerås, 
2005). Cows with substantial S. aureus growth in milk samples are at high risk of being culled 
(Reksen et al., 2006). A study by Piccinini et al. (2003a) reported substantial milk losses in 
herds with S. aureus mastitis compared with herds in which the pathogen was not detected. 
The relative losses were greatest in herds with fewer than 150 cows. The losses listed above 
were of direct economic importance, but mastitis is also an animal welfare issue. 
 
Economic losses due to S. aureus mastitis may be higher than for an average case of mastitis, 
especially in primiparous cows (Gröhn et al., 2004). Multiparous cows are generally more 
often infected with S. aureus as compared with heifers (McDougall et al., 2007). However, 
high prevalences of S. aureus IMI have occasionally been reported for heifers.  Fox et al. 
(1995) reported that 9% of refreshening heifers in Louisiana had S. aureus mastitis. Waage et 
al. (1999) recorded S. aureus in approximately 44% of the bacteriologically-positive quarters 
of 1040 heifers with clinical mastitis. Myllys et al. (1995a) isolated S. aureus in 20% of the 
quarter secretion samples taken from 265 heifers in 160 Finnish dairy farms. 
 
Under certain environmental conditions, many S. aureus strains are able to produce a variety 
of enterotoxins, which can cause food poisonings (Jørgensen et al., 2005b). These toxins are 
not inactivated by pasteurisation or other heat treatment of milk. S. aureus can also be a 
zoonotic pathogen, even though it is generally regarded as rather host-specific. However, 
direct transmission of MRSA between cows and humans was recently reported (Juhász-
Kaszanyitzky et al., 2007). 
2.1.2 Reservoirs and transmission 
Anterior nares are the natural niche of S. aureus in humans and the microbe is frequently 
present on the skin, skin glands and mucous membranes of many individuals. Approximately 
20% of healthy people are persistently colonised by S. aureus in the anterior nares, and up to 
70% carry it at least intermittently (Kluytmans et al., 1997). Presence of S. aureus is regarded 
as a risk factor for staphylococcal infection (Saginur et al., 1996). 
 
Dairy cows, among other domestic artiodactyls, are considered to be temporary hosts of S. 
aureus, in which the microbe is frequently present as a contaminant that can multiply and 
persist for short periods (Kloos, 1997). S. aureus has been isolated from practically all 
external surfaces of healthy cows (Davidson et al., 1961; Matos et al., 1991; Roberson et al., 
1994; Roberson et al., 1998), udder skin being the preferred site (Schalm et al., 1971; 
Jørgensen et al., 2005a). Long-term colonisation by S. aureus on teat skin and several other 
body sites, primarily mucosal external orifices, have been observed in heifers (Roberson et 
al., 1994) suggesting persistent colonisation. It its likely that a calf has its first contact with S. 
aureus already at birth via the genital area of the mother. Even though S. aureus has been 
found to survive in the barn environment, such as in bedding material, on the floor, in dust, 
and in feed (Davidson et al., 1961; Davidson et al., 1963; Matos et al., 1991), it cannot be 
considered an environmental bacterium (Kloos, 1997). 
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Mastitis caused by S. aureus is considered to be contagious, as the diversity of mastitis-
causing strains is low, suggesting a common source of infection (Larsen et al., 2000a; 
Buzzola et al., 2001) and control programs planned for contagious mastitis have reduced 
occurrence of S. aureus (Hoblet and Miller, 1991; Wilson et al., 1995). Infected milk is 
generally considered to be the primary source of the microbe, and milking liners are the main 
vector of transmission of mastitis-causing S. aureus, since they have been frequently shown to 
be contaminated with similar S. aureus strains to those in infected milk (Fox et al., 1991; 
Larsen et al., 2000a; Zadoks et al., 2002; Jørgensen et al., 2005a). Traumatised sites such as 
abrasions on teats, legs, bends and navel, typically infected by S. aureus, are regarded as 
secondary sources of S. aureus causing IMI. 
 
S. aureus is regarded as a clonal organism as the populations consist of groups of genetically 
related strains with a common ancestor. S. aureus diversifies more often by point mutation 
than by horizontal gene transfer (Feil et al., 2003). S. aureus strains isolated from mastitic 
milk and different body sites in dairy cows have been diverse (Joo et al., 2001; Middleton et 
al., 2002a; Zadoks et al., 2002), but in many areas (Annemüller et al., 1999; Buzzola et al., 
2001; Zschöck et al., 2004) and even worldwide (Smith et al., 2005b), a small subset of 
strains is considered to be involved in the majority of mastitis cases. Most studies have 
demonstrated that a given herd usually harbours a limited number of S. aureus strains, often 
with one or a few strains predominating (Kapur et al., 1995; Fitzgerald et al., 1997; Larsen et 
al., 2000a; Buzzola et al., 2001; Sommerhäuser et al., 2003; Mørk et al., 2005; Rabello et al., 
2007). The strains of this subset have been shown to be genetically related and have probably 
differentiated from a common parental strain (Smith et al., 2005b). By contrast, most strains 
detected at extramammary sites, such as the udder and teat skin, differ genetically from the 
mastitis strains (Zadoks et al., 2002), which suggests that strains have evolved that specialise 
in infecting bovine intramammary tissue. 
 
Identical S. aureus strains have occasionally been isolated from dairy cows and hands of 
milking personnel (Jørgensen et al., 2005a), but strains originating from bovine mastitis in 
general represent a genetically different cluster than the human strains, suggesting host-
specificity (van Leeuwen et al., 2005). Part of this specificity or host-adaptation may be due 
to acquisition or loss of mobile accessory genetic elements, which are present in different 
strains to various degrees (Fitzgerald and Musser, 2001). 
2.1.3 Clinical manifestation and outcome 
Clinical manifestation of bovine mastitis caused by S. aureus following IMI can vary from 
subclinical to a peracute, gangrenous form (Barkema et al., 2006). Subclinical mastitis is the 
most common and likely the most problematic. The only detectable response is an increased 
milk SCC but the pathological changes; reduced secretory cell and luminal areas, lead to 
lowered quality and quantity of milk production. Unfortunately, milk SCC may remain under 
threshold limits and infection is often chronic when detected. S. aureus mastitis generally 
responds poorly to treatment (Barkema et al. 2006), relapses are common, and the infection is 
easily transmitted to unaffected quarters of the same cow. Virulence of the infecting strain and 
host factors, including the efficacy of the immune response of the cow, which may be related 
to age and lactation stage, are assumed to affect the severity of the clinical signs and 
persistence of infection. Older cows are more often infected with S. aureus compared with 
primiparous cows and develop more severe inflammation (Pyörälä and Pyörälä, 1997; 
McDougall et al., 2007). High SCC in the affected quarter and multiple infected quarters in 
the same cow impair the prognosis (Sol et al., 2000; Zadoks et al., 2001). 
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2.1.4 Antimicrobial resistance of bovine Staphylococcus aureus 
S. aureus exhibits resistance to a wide range of antimicrobial agents including disinfectants 
(Bjørland et al., 2001). In the Nordic countries, antimicrobial resistance of mastitis-causing 
bovine S. aureus is generally less common than in many other countries. In Norway and 
Sweden, the proportion of penicillin resistant isolates has remained below 10% (SVARM, 
2002; NORM-VET, 2005). In the rest of the Europe, the proportion of penicillin resistant 
isolates has ranged from 23% (DANMAP, 2003) up to 69% (Nunes et al., 2007), in the 
United States from 38 to 61% (Erskine et al., 2002) and was reported to be 40% in Argentina 
(Gentilini et al., 2000). Penicillin resistance is due to expression of inducible β-lactamase 
(penicillinase until 1960) encoded by the blaZ gene, which causes hydrolysis of the β-lactam 
ring of penicillin. The first reports on the ability of S. aureus to break down penicillin were 
published in 1940, a year before the antimicrobial was introduced for therapeutic use 
(Abraham and Chain, 1940). Impaired treatment response has been associated with penicillin 
resistance of the infectious S. aureus strain (Sol et al., 2000; Taponen et al., 2003). However, 
the connection is not straightforward, which may indicate that some other bacterial factors 
could be involved in the phenomenon (Barkema et al., 2006). 
 
Introduction of antimicrobials such as tetracycline, aminoglycosides and macrolides into 
mastitis therapy has been accompanied by the emergence of corresponding resistance in 
bovine S. aureus strains (Myllys et al., 1998). Acquisition of modified penicillin-binding 
proteins (PBP) has made some S. aureus strains resistant to all β-lactams. This property, 
called methicillin resistance, has been uncommon among bovine S. aureus isolates to date 
(Monecke et al., 2007; Moon et al., 2007). The recent emergence of vancomycin resistant S. 
aureus strains in human medicine has made control of S. aureus infections increasingly 
difficult (Jones, 2008). 
2.1.5 Control 
The “five point plan” plan developed by mastitis experts decades ago (Neave et al., 1969) for 
control of contagious mastitis has been applied worldwide. The main goal of the programme 
was to eradicate Streptococcus agalactiae and S. aureus from cattle herds. The elements were 
post-milking teat disinfection, total dry cow therapy, appropriate therapy of clinical cases 
during lactation, proper maintenance of the milking machinery and culling of chronically 
infected cows. The five point plan, or some of its components, have considerably reduced Str. 
agalactiae mastitis, but for S. aureus mastitis the effect has been less satisfactory. Segregation 
of the infected cows alone has not been sufficient (Fox et al., 1991), cure rates for dry-cow 
therapy have been low, ranging from 40 to 70% (Leslie and Dingwell, 2003) and there is no 
scientific evidence to suggest that that culling alone is economic. Epidemiological studies of 
S. aureus in the environment of dairy cows have increased knowledge on the dynamics of S. 
aureus IMIs. Current strategies for control and prevention of S. aureus mastitis have been 
expanded to include isolation or elimination of the reservoir by segregation, therapy, and/or 
culling, isolation or removal of the fomites by applying improved milking hygiene, evaluation 
of teat skin condition, teat disinfection and backflush. In some countries, host resistance has 
been enhanced by improving management of the cows and vaccinating against mastitis 
(Talbot and Lacasse, 2005). 
 
In spite of the introduction of large-scale mastitis control programmes, S. aureus remains a 
major mastitis pathogen. It causes mastitis epidemics even in well-managed dairy herds 
(Smith et al., 1998) and can persist for long periods in the mammary glands (Raimundo et al., 
 16 
1999; Larsen et al., 2000a; Anderson and Lyman, 2006). The current control practices may 
fail to prevent the spread of particularly virulent strains. Kapur et al. (1995) suggested that 
control of S. aureus mastitis should be focused on specific strains causing infections in the 
herds. 
2.2 Pathogenesis of bovine Staphylococcus aureus intramammary infection 
An infection like IMI can be considered a condition where adverse colonisation by a microbe 
has occurred in the host animal. Inflammation, the host’s response to the microbe, is seen as 
swelling, redness, pain, heat and interference in the normal function of the affected organ. The 
general term for inflammation of the mammary gland is mastitis, which can occur with or 
without infection. 
 
Development of S. aureus infection in the bovine mammary gland can be divided into the 
following stages: entry and attachment of S. aureus bacteria in the mammary gland, 
interaction between the bovine immune system, evasion of immune defence, survival and 
tissue invasion. Entry of S. aureus into the teat canal can lead to IMI, but this depends on 
certain conditions as for any infection: the initial number of bacteria, access of the microbe to 
the target tissue, virulence of the strain and immunity of the host (Projan and Novick, 1997). 
2.2.1 Entry and attachment of Staphylococcus aureus into the mammary gland 
Entry of a sufficient number of S. aureus bacteria via the teat canal into the mammary gland is 
required for the development of natural IMI. The infective dose of S. aureus in bovine IMI is 
not known precisely, but quantities as small as 10 cfu have caused infection in an 
experimental model where bacteria were infused directly into the teat duct (Reiter et al., 1970; 
Postle et al., 1978). However, infection did not develop in all cows in experimental infection 
models (Schukken et al., 1999), which suggests that S. aureus does not always multiply 
sufficiently in the mammary gland, but other predisposing factors need to be present. 
 
First line defence mechanisms against invasion of S. aureus are the physical barriers of the 
teat canal. A tightly constricted teat canal rapidly closes the end of the teat apex between 
milkings. Keratin material covering intact teat canal epithelium inhibits bacterial growth, 
although heifers have sometimes harboured S. aureus in this tissue (Trinidad et al., 1990). 
  
Attachment of S. aureus to host cells or extracellular matrix molecules is a critical step for 
colonisation and intramammary infection. Adherence to these substances is thought to occur 
by non-specific physicochemical mechanisms and by specific bacterial host-cell binding 
(Kluytmans et al., 1997). The bacteria must then resist flushing of milk until adherence to the 
epithelial cells lining the ductules and alveoli of the mammary gland is accomplished (Frost et 
al., 1977). S. aureus adheres to bovine mammary epithelial cells better than most other 
bacterial species (Frost et al., 1977) and the presence of milk enhances adherence (Mamo and 
Fröman, 1994). Attachment is best to fully mature cells, such as keratinised epithelial cells, 
compared with the cells of the deeper epidermis (Aly and Levit, 1987). Adherence to teat 
canal cells depends on the origin of the cell type (Sutra and Poutrel, 1994). S. aureus adheres 
particularly well to the cells of the upper part of the mammary gland (Frost et al., 1977). S. 
aureus is also able to adhere to fat globules, which allows dissemination to the upper part of 
the gland by floating (Sandholm et al., 1989). 
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Teat traumas increase the risk of colonisation of the teats by S. aureus. Epithelial damage 
reveals the underlying subepithelial components, e.g. fibrinogen and collagen, which allows 
staphylococcal surface proteins to mediate adherence to the host cell matrix (Patti et al., 
1994). Exotoxins secreted by S. aureus can also be involved in the epithelial damage (Mamo 
et al., 1988). Even minor traumas, such as those from milking, can facilitate entry of S. aureus 
into the teat. Callusing of the teat canal prevents tight closing and extremely callused teats 
were shown to be more susceptible to S. aureus mastitis (Zadoks et al., 2001). A study by 
Myllys et al. (1994b) demonstrated that teat canal colonisation, teat canal infection and IMI 
were far more common in quarters where the teat orifice epithelia were experimentally 
abraded compared with control quarters. Animal experiments have shown that very large 
numbers of viable staphylococci are needed to cause cutaneous or subcutaneous infection, 
unless a foreign body is present (Noble, 1965; Bunce et al., 1992). On the other hand, minor 
traumas such as depilation or removal of the outer layers of epithelium due to removal of 
adhesive surgical tapes, have led to skin infection in humans if S. aureus is applied and the 
area occluded  (Singh et al., 1971). 
2.2.2 Interaction between Staphylococcus aureus and the bovine immune system 
The second line of defence comprises the innate immune system that includes defence cells 
(neutrophils, macrophages, natural killer cells, and dendritic cells) and humoral factors 
(lactoferrin, lysozyme, lactoperoxidase, protein A, and complement) present in the teat duct 
and in the milk (Rainard, 2003; Rainard and Riollet, 2003). Bacterial colonisation leads to 
influx of somatic cells, primarily polymophonuclear neutrophils (PMN), as response to 
cytokine production triggered by the bacteria. Phagocytosis and killing by leukocytes play the 
main roles in host defence against S. aureus infection. Numerous exoproteins, like SAgs 
secreted by S. aureus, can interfere with phagocytosis (Verhoef, 1997). Phagocytosing cells 
express ingested staphylococci or their products in association with MHC II molecules on 
their surface in order to present them to T cells. Accumulation of neutrophils and capsule 
formation often surrounds gland areas infected by S. aureus and the bacteria remain sheltered 
within furuncles or abscesses. 
 
S. aureus may avoid intracellular death and survive within the host cells (Mullarky et al., 
2001), where it is protected from the host defence mechanisms and effects of antimicrobials. 
S. aureus is not regarded as an intracellular microorganims but replication within bovine 
mammary epithelial cells has been demonstrated (Almeida et al., 1996). In the intracellular 
environment, S. aureus can fall into nutritional stress but still survive. These so-called small-
colony variants grow slowly and have typical colony morphology, due to altered metabolism, 
but they are infective and are highly resistant to antimicrobials (Proctor et al., 1998; 
Brouillette et al., 2004). Secreted cytolytic toxins allow S. aureus to be released from the 
intracellular environment. 
2.3 The role of bacterial virulence factors in Staphylococcus aureus intramammary 
infection 
According to the narrowest definition, a virulence factor is a substance that when purified to 
homogeneity and introduced into a test animal, produces a pathogenic effect. By using this 
definition factors involved in attachment cannot be considred to be virulence factors. In the 
broadest sense, any factor produced out of the bacterial cytoplasm allowing survival within or 
on a host organism in a non-symbiotic manner can be regarded as a virulence factor (Projan 
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and Novick, 1997). S. aureus can produce numerous putative virulence factors that allow the 
microbe to adhere to eukaryotic membranes, resist phagocytosis, lyse eukaryotic cells and 
trigger the production of a cascade of host immunomodulating molecules. Among bovine S. 
aureus isolated from mastitis, production of enterotoxins (Aarestrup et al., 1999; Larsen et al., 
2000b; Tollersrud et al., 2000b) or genes encoding these toxins have been the most studied 
(Salasia et al., 2004; Zschöck et al., 2004; Fueyo et al., 2005; Srinivasan et al., 2006). Many 
suggest that virulence of bovine S. aureus vary among strains (Smith et al., 1998; Raimundo 
et al., 1999; Larsen et al., 2000a; Zadoks et al., 2000; Sommerhäuser et al., 2003), but the 
possible role of specific virulence factors in this phenomenon is poorly understood. 
 
In general, S. aureus virulence factors can be divided into those involved in attachment and 
into those enabling evasion of the host immune system and tissue invasion (maintenance of 
infection). 
2.3.1 Control and expression of virulence factors 
Virulence factors of S. aureus are not essential for bacterial cell division and growth, and 
many of these are needed only in certain circumstances. Continuous secretion of the virulence 
factors would be uneconomic for the microorganism. Therefore, expression of S. aureus 
surface proteins and exoenzymes is a coordinated process, which depends on the phase of 
bacterial growth and environmental stimuli (Horsburgh, 2008). The coordination is made by 
the aid of well-characterised global regulatory elements, those of sar locus (staphylococcal 
accessory regulator) and two-component regulatory systems like agr locus (accessory gene 
regulator), and sae (staphylococcal accessory element) (Fournier, 2008). 
 
By culturing S. aureus in idealised medium it has been shown that surface proteins involved 
in attachment are produced when the bacterial cell growth and division is exponential (Figure 
1). sar upregulates production of many of the surface proteins during this phase. sar is able to 
up-modulate the agr locus. The agr is a quorum-sensing system, which turns off the 
expression of surface proteins and upregulates transcription of several virulence factors in 
response to increased cell density during the postexponential phase of growth. Other less well 
characterised regulators and proteins such as sigma factor σ and rot (Fournier, 2008) are also 
involved in the regulation of virulence factor production. 
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Figure 1. The expression and control of S. aureus of putative virulence factors during the bacterial 
growth cycle in idealized medium.↑ = upreglation, ↓ = downregulation. PXP = postexponential, STA 
= stationary. Adapted from Projan and Novick (1997) and from Fournier (2008). 
2.3.2 Virulence factors involved in establishing an infection 
S. aureus can produce several adhesins or MSCRAMMs, which have been shown to mediate 
attachment to various cell surface proteins such as collagens, elastin, fibrinogen, fibronectin, 
bone sialoprotein, laminin and thrombospondin (Foster and Höök, 1998). Ligations to these 
proteins enable S. aureus to colonise tissues and initiate infection (Patti et al., 1994, 
Brouillette et al., 2003). FnBPs have been demonstrated to be involved in cell invasion 
(Dziewanowska et al., 1999) and to mediate adhesion to platelets via fibronectin and 
fibrinogen (Heilmann et al., 2004). S. aureus is capable of invading eukaryotic cells and 
phagocytosing cells, and antibiotics are unable to reach the intracellular bacteria (Balwit et al., 
1994). In this invasion S. aureus uses its surface-expressed FnBPs (Lammers et al., 1999) and 
α1β5-integrin on the host cell surface (Sinha et al., 1999). 
 
S. aureus can adhere to the polymer surface of plastic material, to form microcolonies, and to 
produce extracellular slime or glycocalyx, which forms a biofilm covering the bacteria 
(Donlan and Costerton, 2002). FnBPs are evidently required for adhesion to fibronectin-
coated surfaces, e.g. those in medical devices, as double mutants have been shown to be 
unable to adhere (Greene et al., 1995). Furthermore, FnBPs have recently been demonstrated 
to mediate biofilm formation (O’Neill et al., 2008). 
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2.3.3 Virulence factors involved in maintenance of infection 
The factors involved in maintenance of infection include haemolysins, leukocidins, SAgs, 
nucleases, proteases and lipases. 
  
Haemolysins are cytotoxic agents that damage and/or destroy cells of the defence system. 
Alpha-haemolysin (α-toxin), frequently produced by bovine S. aureus IMI isolates (Aarestrup 
et al., 1999; Akineden et al., 2001), is toxic to bovine mammary cells (Bramley et al., 1989), 
causes erythrolysis, disturbs the host cell ion balance, is dermonecrotic and neurotoxic 
(Dinges et al., 2000), is needed in biofilm formation (Caiazza et al., 2003) and plays a 
putative role in peracute, toxic bovine S. aureus mastitis (Jones and Wieneke, 1986; 
Matsunaga et al., 1993). Beta-haemolysin (β-toxin), probably produced by most of the bovine 
strains (Aarestrup et al., 1999), functions as sphingomyelinase of the erythrocytes. 
Susceptibility of erythrocytes to β-haemolysin varies depending of the sphingomyelin content 
of the target cell, e.g. sheep erythrocytes are easily lysed whereas rabbit erythrocytes are not 
(Doery et al, 1965). Based on in vitro studies, β-haemolysin has been thought to increase the 
damaging effects of α-haemolysin and enhance the attachment of S. aureus on bovine 
mammary epithelial cells (Cifrian et al., 1995; Cifrian et al., 1996). Delta-haemolysin has 
surfactant or channel-forming properties and it intensifies haemolytic effects of β-haemolysin 
(Dinges et al., 2000). Haemolysin γ is toxic to monocytes and macrophages and lyses red 
blood cells and phagocytes (Projan and Novick, 1997). Concomitant production of α and γ-
toxin promoted S. aureus virulence in murine septic arthritis (Nilsson et al., 1999). 
 
The family of leukocidins comprises toxins that damage membranes of phagocytosing host 
defence cells by inducing Ca2+ influx and subsequent pore formation. Leukocidins are 
composed of two subunits of related proteins, class S (slow eluting) and F (fast-eluted) 
proteins, the toxic effect depending on the synergistic action of both of these proteins (Kamio 
et al., 1993). The family includes Panton-Valentine leukocidin PVL (LukS-PV + LukF-PV), 
γ-haemolysin and leukocidin (Hlg and Luk; HlgA + LukF and LukS + LukF), LukM/FPV 
(LukM + LukF-PV), LukE/D (Kamio et al., 1993; König et al. 1995; Prevost et al., 1995), and 
LukR-PV, detected in strain P83 originating from bovine mastitis (Supersac et al., 1993). 
Leukocidins are more leukotoxic that γ-haemolysin (Prevost et al., 1995). 
 
The family of staphylococcal SAgs includes enterotoxins and enterotoxin-like proteins (SEA-
SEE, SEG-SER, and SEU), toxic shock syndrome toxin (TSST), and exfoliatins ETA and 
ETB. SAgs have at least three biological properties: pyrogenicity, superantigenicity (Dinges 
et al., 2000) and the ability to enhance the lethality of rabbits to endotoxin shock up to 
100 000 fold in experimental models, where TSST-1 and endotoxin have been administered to 
test animals (Schlievert, 1982). SAgs bind to the outer surface of the MHC class II proteins 
and outside the site in T-cell receptors, to which antigens normally bind. The normal antigen 
presentation mechanism is bypassed and consequently as much as 30% of the T-cells are 
activated instead of the normally of 0.1‰ activated T-cells (Fleischer and Schrezenmeier, 
1988). This results in massive and uncontrolled release of cytokines, and in capillary leak, 
hypovolemic shock and multiorgan failure as seen in the toxic shock syndrome (Dinges et al., 
2000; McCormick et al., 2001; Alouf and Müller-Alouf, 2003). Peracute bovine S. aureus 
mastitis has been suggested to be such a reaction. The condition is rare and from the 
viewpoint of the bacterium it is unfavourable because the host will normally die. SAgs can 
stimulate macrophages and monocytes to produce several inflammatory mediators, including 
tumour necrosis factor-α, nitric oxide, interleukin-6 and IL-10. Furthermore, in the presence 
of interferon-γ, the macrophages become cytolytic (Fleming et al., 1991). SAgs are 
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considered to facilitate S. aureus to evade host defence systems and are thus suggested to 
contribute both to acute and chronic bovine mastitis. Ferens et al. (1998) reported that SEC 
affected the bovine immune system by increasing the proliferation of CD8+ T-cells, resulting 
in suppression of CD4+ T-cells. SAgs may help S. aureus persist in mucosal membranes 
(Ferens and Bohach, 2000). 
 
Most S. aureus strains produce a capsule and slime that can enhance adhesion to endothelial 
cells, inhibit phagocytosis, and hide the bacteria from antimicrobials and antibodies when 
subsequent opsonisation and phagocytosis fail (Lee et al., 1994; Verhoef, 1997). Protein A, a 
cell wall-associated protein, interacts with several host factors including immunoglobulins G, 
A, E, tumour necrosis factors, and platelets attenuating opsonisation and phagocytosis 
(Peterson et al., 1977; Gomez et al., 2004). Binding of IgM associated with B cells by protein 
A induces apoptosis, a mechanism leading to death of host cells such as PMN and 
macrophages (Menzies and Kourteva, 1998; Goodyear and Silverman, 2004). Coagulase, a 
prothrombin activator that converts fibrinogen to fibrin and causes clotting of cells, is 
produced by the majority of S. aureus strains. It possibly has a role as a virulence factor 
(Phonimdaeng et al., 1990; Lowy et al., 2000). Lipases, esterases, fatty acid modifying 
enzyme (FAME) and phospholipases function as surfactants against a variety of fatty acids 
and other lipid molecules that host cells produce in order to destroy the bacterial membrane 
(Chamberlain and Imanoel, 1996; Arvidson, 2000). 
2.3.4 Immunity to Staphylococcus aureus 
Infection by S. aureus can induce a strong antibody response to many bacterial antigens 
(Bonventre et al., 1984), but a long-term protective immunological memory does not seem to 
develop (Talbot and Lacasse, 2005). During S. aureus IMI, peripheral anti-staphylococcal 
antibody titers are correlated with milk antibodies, the levels being lower in milk. Bovine 
IgG1, IgG2 and IgM opsonise S. aureus, and IgA functions as a neutralising antibody. The 
levels of IgG1 are highest in mammary glands (Schalm et al., 1971). S. aureus possesses 
numerous mechanisms that interfere with the innate immune response of the host, including 
inhibition of complement activation and neutralisation of antimicrobial peptides (Chavakis et 
al., 2007). The effect of genetic polymorphism of innate immune factors between human 
individuals on nasal carriage by S. aureus was recently studied by van Belkum et al. (2007). 
2.4 Typing of bovine Staphylococcus aureus 
Typing of S. aureus is important for epidemiological investigations, to determine the sources 
of infection, routes of transmission in disease outbreaks and presence of strains of different 
virulence. Staphylococcal typing can be categorised as phenotypic or genotypic. During 
recent decades, several genotypic methods have superseded many of the traditional 
phenotypic methods. Genotyping is often combined with suitable phenotypic data, such as 
profiles for antimicrobial resistance. This is recommended, for example, in the 
epidemiological evaluation of clonal relatedness of isolates (Tenover et al., 1994). 
2.4.1 Phenotypic methods 
Antibiogram typing, i.e. determining susceptibility of the isolates to a selection of 
antimicrobials, has been a widely used phenotypic method in the characterisation of S. aureus 
originating from bovine mastitis (Myllys et al., 1998; Østerås et al, 2006). This method can be 
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useful for initial screening of multiresistant strains or strains resistant to a given, important 
antibiotic such as penicillin. For epidemiological purposes this method has relatively poor 
discriminatory power. Furthermore, many of the tested susceptibility characteristics can be 
very unstable due to presence of extrachromosomal plasmids for instance. 
 
In biotyping, isolates of S. aureus are differentiated by means of cultural and biochemical 
properties. The discriminatory power of biotyping is relatively low, and non-typable isolates 
are frequent. Differentiation of S. aureus capsular types using serotyping has been applied to 
bovine mastitis isolates (Guidry et al., 1998; Sordelli et al., 2000; Tollersrud et al., 2000a; 
Tollersrud et al., 2000b), aiming to develop vaccines against staphylococcal capsular 
polysaccharides (Sordelli et al., 2000). Non-typable isolates are common (Tollersrud et al., 
2000a; Tollersrud et al., 2000b). 
 
In phage-typing, the sensitivity of staphylococcal isolates to a standard collection of 
bacteriophages is tested. Thorne and Wallmark (1960) were probably the first to use phage-
typing in epidemiological studies on S. aureus mastitis. Fox et al. (1991) used phage typing to 
study the importance of milkers' hands and milking unit liners as fomites, and teat skin as a 
reservoir of S. aureus IMI. Phage-typing is no longer used due to lack of discrimination, large 
numbers of non-typable strains, changing phage patterns of a given strain over time and 
complex technical requirements. 
 
Multi-locus enzyme electrophoresis (MLEE) compares electrophoretic mobility variation in a 
set of housekeeping enzymes (Selander et al., 1986). Kapur et al. (1995) and Tollersrud et al. 
(2000b) applied MLEE to studying population genetics and epidemiology of mastitis-causing 
bovine S. aureus. 
2.4.2 DNA-based methods 
Ribotyping compares the numbers and sizes of DNA fragments separated by conventional 
electrophoresis and obtained by cleaving bacterial DNA with a frequent cutter enzyme. The 
method is regarded as unsuitable for routine laboratory tests as it is laborious and technically 
demanding (Deplano and Struelens, 1998). 
 
Strain differentiation by binary typing is made by hybridisation with RAPD-generated DNA 
probes to target sequences in the S. aureus genome. Absence or presence of a given sequence 
is binary coded, resulting in a numerical type (van Leeuwen et al., 1999). The discriminatory 
power of binary typing is higher than even that of PFGE (van Leeuwen et al., 1999), but the 
method does not provide information on genetic relatedness of the strains. 
 
MLST is based on sequence variation of seven chromosomally encoded housekeeping genes. 
The method provides sequence data that can be used for prediction of evolutionary 
development. MLST has been used in studies on host specificity (Herron-Olson et al., 2007) 
and global epidemiology of bovine S. aureus clones (Smith et al., 2005b; Rabello et al., 
2007). 
 
In PFGE the bacterial genome is cleaved with a rare-cutting enzyme (mostly Sma1) to 10-30 
large fragments ranging in size from 10 to 800 kb. Sufficient fragment separation is obtained 
by electrophoresis, where the current changes polarity in pulses. PFGE, currently regarded as 
the gold standard method, is highly reproducible and discriminatory, and coordinated inter-
laboratory surveillance has allowed development of standardised protocols (van Belkum et 
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al., 1998; Murchan et al., 2003). PFGE has been widely applied in typing bovine S. aureus 
(Zadoks et al., 2000; Buzzola et al., 2001; Joo et al., 2001; Zadoks et al., 2002; Middleton et 
al., 2002a; Middleton et al., 2002b; Jørgensen et al., 2005a; Hata et al., 2006; Aires-de-Sousa 
et al., 2007; Peles et al., 2007; Rabello et al., 2007). The method has been specifically applied 
to study the effect of S. aureus genotype on manifestation of mastitis (Zadoks et al., 2000; 
Middleton et al., 2002a), to determine the origin of mastitis-causing strains (Zadoks et al., 
2002), to evaluate the effect of genotype on long-term persistence of S. aureus in dairy herds 
(Anderson and Lyman, 2006) to assess recovery from mastitis caused by different S. aureus 
genotypes (Dingwell et al., 2006), and to study genetic relationship of strains expressing or 
carrying specific virulence determinants causing particular disease like food poisoning 
(Jørgensen et al., 2005b). PFGE is the method of choice for comparison of epidemiologically 
related isolates. 
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3. AIMS OF THE STUDY 
1. To determine the prevalence of intramammary infections caused by S. aureus in Finnish 
dairy herds, based on data collected during a national mastitis survey, and to study the 
occurrence of S. aureus in intramammary infections and extramammary sites in two Finnish 
dairy herds managed under different regimes.  
 
2. To assess the diversity of S. aureus isolates by genotyping and by identifying particular 
genes in S. aureus isolated from intramammary infections. 
 
3. To investigate antimicrobial resistance of S. aureus isolated from bovine mastitis using 
phenotypic and genotypic methods, with special reference to penicillin and methicillin 
resistance. 
 
4. To study the relationship between S. aureus genotypes, presence of specific genes, and 
severity and persistence of intramammary infections.  
 
5. To study the potential reservoirs and transmission of S. aureus causing bovine mastitis in 
two dairy herds maintained under different management regimes. 
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4. MATERIALS 
4.1 Origin of Staphylococcus aureus isolates 
The first part of the thesis (I) represents results of the third nationwide survey conducted in 
Finland in 2001 to estimate prevalence and distribution of bovine mastitis, and in vitro 
antimicrobial susceptibility of the isolated mastitis pathogens. Dairy advisors collected herd 
data and milk samples from 3282 dairy cows on the 216 participating farms. This represented 
a random sample of 270 farms from a national database that included all dairy farms in 
Finland. Among the 12 661 milk samples collected, 430 harboured S. aureus. 
 
In studies II-III, the S. aureus isolates (n = 217), including clinical data, were collected from 
field cases of S. aureus mastitis in 116 cows with 141 infected quarters. The samples were 
collected between September 1993 and January 1997 in the practice area of the Ambulatory 
Clinic, Faculty of Veterinary Medicine, University of Helsinki. The 217 S. aureus isolates 
comprised 134 isolates collected at the onset of mastitis and 83 collected during the follow-up 
period. Seven of the 83 isolates were from new quarters infected during the follow-up period. 
 
In study IV, S. aureus isolates originated from two Finnish dairy herds in southern Finland. 
The isolates were collected from all IMIs diagnosed during a 10-month period from October 
2002 to August 2003, and from extramammary sites (dairy cow teat skin, teat canals and skin 
lesions; milking liners; hands and nostrils of milking personnel) sampled during one farm visit 
to both herds. Prior to the study, S. aureus mastitis in the herds was estimated to affect 10-20% 
of the cows. 
4.2 Study animals and herds 
The cattle breeds in study I were Finnish Ayrshire (42.1%), Holstein-Friesian (14.0%), other 
breeds (1.0%), and mixed breeds (42.9%). The cows were from herds with a mean size of 17.3 
cows, average parity of 2.5, mean annual milk production of 7505 kg and average geometric 
mean for SCC of 116 000 cells/ml of milk. The majority of the farms had stanchion-barns 
(89.8%) and the rest had loose-house systems (6.9% warm and 3.2% cold systems). 
 
Most cows in studies II-III were of the Finnish Ayrshire breed, some were Holstein Friesians 
or of mixed breed and very few cows were of the Finnish Landrace breed. The cows were 
from 70 dairy herds and represented approximately 60% of the individual cows treated for S. 
aureus mastitis by the Ambulatory Clinic during this period. The herds were included in a 
health recording system, where all veterinary treatments were recorded and BMSCC was 
regularly monitored. The mean milk production of these herds was not recorded. All herds 
were housed in stanchion barns. 
 
In study IV, Herd I comprised an average of 30 lactating Holstein-Friesian cows with mean 
annual milk production of 9600 kg. No replacement heifers or cows were integrated from 
other herds (closed herd). The cows were kept in a loose-house system during the indoor 
season and were milked twice a day in a milking parlor. Herd II comprised an average of 54 
Ayrshire cows with mean annual milk production of 9185 kg. Young replacement heifers 
from all over in Finland were purchased (open herd), and the cows were housed and milked in 
a stanchion-barn. 
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5. METHODS 
5.1 Clinical examination of the cows and mastitis follow-up (II-IV) 
Clinical signs were recorded and the outcome of mastitis was followed by the veterinarians of 
the Ambulatory Clinic in studies II-III. The herdsmen controlled milk appearance by stripping 
before every milking and estimated quarter milk SCC using a CMT test. If the cow showed 
clinical signs of mastitis or elevated milk SCC as estimated by the CMT test (Klastrup and 
Schmidt Madsen, 1974), the farmers were advised to call the attending veterinarian of the 
Ambulatory Clinic. The veterinarian examined the cow, recorded clinical signs, scored milk 
SCC using CMT from each lactating quarter, collected the milk samples and started the 
treatment based on herd-level history of mastitis-causing bacteria and their antimicrobial 
susceptibility. Within approximately 20 hours of the veterinarian’s visit, preliminary results 
based on routine identification of bacteria and testing of β-lactamase production of 
staphylococci were available at the laboratory of the Ambulatory Clinic. The treatment was 
continued according to the laboratory results. Cows infected with β-lactamase negative 
isolates were treated with penicillin G i.m. for 5 days. If the isolate was β-lactamase positive, 
cows with clinical mastitis were treated with amoxycillin clavulanate i.m. and i.m.m. and 
those with subclinical mastitis with cloxacillin i.m.m. for 5 days. The veterinarian revisited 
the cows approximately 2 and 4 weeks post-treatment for follow-up sampling and clinical 
examination. 
 
In study IV herds (Herds I and II) the herdsmen monitored the cows as in studies II-III, but 
they contacted the herd veterinarian. In Herd II, cows with subclinical S. aureus IMI were 
usually not treated, but the affected quarter was prematurely dried-off, especially if the isolate 
was penicillin-resistant (produced β-lactamase). 
5.2 Sample collection  
5.2.1 Milk samples 
Quarter foremilk samples were collected aseptically for bacteriological culturing as described 
by Honkanen-Buzalski (1995). Before sampling, the first streams of milk were discarded and 
teat ends were disinfected with cotton swabs soaked in 70% alcohol and allowed to dry. The 
samples were kept on ice until in the laboratory. The milk samples for SCC analysis by 
fluoro-optic counting were preserved with sodium azide (I). In study I, dairy advisors 
collected quarter milk samples from all milk-producing cows at the farms and submitted the 
samples. In study IV, both herd staff and veterinarians collected the milk samples and 
submitted them to the laboratories of the Finnish Food Safety Authority and Valio Ltd. 
5.2.2 Samples from extramammary sites (IV) 
Samples from the teat walls, from the teat ends around the teat orifice, teat canals and all 
clearly visible skin lesions (mainly abrasions on the hind legs and a few lesions on teat and 
udder skin), and hands and nostrils of the milking personnel were collected using sterile, 
single-packaged, cotton-tipped swabs (Technical Service Consultants Ltd., Heywood, UK). 
Swabs were moistened with trypticase soy broth (TSB; Oxoid Ltd., Basingstoke, UK) before 
 27
swabbing. Teat canal samples were taken by rotating ultra-fine, sterile, cotton-tipped swabs 
(Deltalab S. A., Barcelona, Spain) 360˚ in the canal. The teat was cleaned, disinfected with 
chlorhexidin solution and dried with a paper towel before inserting the swab into the canal. 
Samples were taken from the hands and nostrils of the staff by rotating the swab 360˚ between 
the bases of the fingers of both hands or in both nostrils. Four random swabs from milking 
liners in Herd I, and swabs from all milking liners in Herd II, were taken prior to milking to 
control the cleanliness of the liners. Milking liners were also sampled after milking each cow. 
The swabs were rotated 360˚ at the point where the liner joined the short milking tube. 
Disposable latex gloves were used during the sampling. After use all swabs were immediately 
placed in sterile plastic containers filled with 5 ml of TSB. The containers were cooled and 
transported to the laboratory within a few hours. 
5.3 Determination of indicators of inflammation in the milk 
5.3.1 Milk somatic cell count 
Quarter-milk SCC was determined using the fluoro-optic method (Fossomatic Milk Analysis, 
Foss Electric, Hillerød, Denmark) in study I. In studies II-IV, milk SCC was estimated from 
quarter milk samples immediately after collection using the CMT test and scoring system 
described by Klastrup and Schmidt Madsen (1974). 
 
A cow and a quarter were considered to have S. aureus IMI when ≥ 500 cfu/ml of S. aureus in 
the quarter milk was detected (I-III). In study IV, the treshold for IMI was 500 cfu/ml for 
quarter milk samples taken by the herdsmen. From the milk samples taken by the 
veterinarians at the farm visit, also quarters with ≥100 cfu/ml of S. aureus in the milk were 
considered S. aureus IMI, if the CMT score was ≥3. Milk samples with bacterial growth of 
more than two species were considered contaminated (I-IV). 
 
Mastitis is a general term used to describe inflammatory conditions of the mammary gland. A 
cow and a quarter were defined as mastitic if the quarter milk SCC exceeded 300 000/ ml (I) 
or if the estimated CMT score was ≥3 using the Scandinavian scoring system (Klastrup and 
Schmidt Madsen, 1974) (II-IV). All quarters with S. aureus in the milk had CMT scores ≥3 at 
the time of the visit by the veterinarian (II-IV). 
5.3.2 Milk N-acetyl-β-D-glucosaminidase (II) 
NAGase activity was determined from quarter milk samples after one cycle of freezing and 
thawing to indicate the inflammatory response of the mammary gland. A fluorogenic NAGase 
assay system described by Mattila and Sandholm (1986) was used with a Fluoroskan® 
microtitration tray reading fluorometer (Labsystems, Helsinki, Finland). The results were 
expressed as arbitrary units (U).  
5.4 Bacterial isolation and conventional identification 
5.4.1 In milk samples 
For bacterial isolation from milk samples, 0.01 ml of milk was cultured on blood-esculin agar 
and incubated for 48 h at 37°C. The plates were examined after 24 and 48 h of incubation and 
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bacterial species were preliminary identified as described by the National Mastitis Council 
(NMC, 1999). The sample was considered contaminated if more than two bacterial species 
were isolated (IDF, 1981; NMC, 1999). S. aureus isolates were stored frozen at -70°C in brain 
heart infusion broth containing 15% glycerol (I) or in commercial storage medium (II-IV; 
Protect Bacterial Preservers, Technical Services Consultants Limited, Heywood, UK). 
5.4.2 In other samples (IV) 
Isolation of S. aureus in samples from extramammary sites was based on descriptions by 
Lancette and Tatini (1992) with the following modifications. After keeping the samples for 30 
min at room temperature, 5 ml of TSB broth containing 20% NaCl was added and the samples 
were vortexed and incubated for 24 h at 37˚C. Subsequently, 0.1 ml aliquots of culture were 
transferred to duplicate plates of Baird-Parker agar and spread with a plastic triangle. The 
plates were incubated at 37˚C for 24 + 24 h. Black, dark grey or shiny brown colonies with 
clear zones of haemolysis were selected for Gram-, catalase-, and rabbit plasma coagulase 
tests. Other colonies suspected of being S. aureus, but without a clear zone, were transferred 
on to acriflavin agar and incubated at 37˚C for 24 h. Colonies with yellow growth were tested 
as potential S. aureus, as previously described. The preliminary identification of S. aureus 
included the following tests: colony morphology, colour and haemolysis on sheep blood agar, 
positive Gram stain, and production of catalase, coagulase, and clumping factor using Slidex 
Staph Kit (bioMérieux, Marcy l’Etoile, France). The isolates were stored at –70 ˚C in Protect 
Bacterial Preservers (Technical Services Consultants Limited, Heywood, UK). 
5.5 Antimicrobial susceptibility testing 
5.5.1 Testing for β-lactamase production 
Production of β-lactamase was tested for using liquid nitrocefin (II-IV), as recommended by 
the manufacturer (Becton Dickinson Microbiology Systems, Cockeysville, MD, USA), or 
using nitrocefin discs (I) (AB Biodisk, Solna, Sweden). S. aureus ATCC 29213 was used as a 
positive control. 
5.5.2 Determination of MIC using the microdilution method (I-II) 
Susceptibility of the isolates to antimicrobials was determined using the VetMIC 
microdilution system (SVA, Uppsala, Sweden). Minimum inhibitory concentration (MIC) 
was recorded as the lowest concentration that inhibited bacterial growth. Calculation of the 
MIC distributions and classification of the results by using breakpoints is described in detail 
in study I. S. aureus isolates with MIC of oxacillin = 2 µg/ ml were retested using an 
oxacillin-salt agar screening test as described by CLSI (2002), including methicillin-resistant 
and methicillin-susceptible S. aureus strains ATCC 43300 and ATCC 29213 as controls. The 
results were classified using the CLSI breakpoints for bacteria isolated from animals (2002), 
when available. 
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5.5.3 Detection of genes encoding β-lactamase and methicillin resistance (III-IV) 
The β-lactamase gene blaZ was detected by primers designed by Vesterholm-Nielsen et al. 
(1999) in PCR conditions described by Haveri et al. (2005). The primers and conditions 
described by Mehrotra et al. (2000) were used for detection of the mecA gene. 
5.6. Characterisation of Staphylococcus aureus isolates using DNA-based methods (II-
IV) 
5.6.1 DNA isolation (II-IV) 
For PFGE typing, DNA was prepared in agarose blocks and digested with SmaI (Boehringer 
Mannheim, Germany) according to Salmenlinna et al. (2000). For PCR studies, DNA was 
isolated using the DNeasy Tissue Kit (QIAGEN, Hilden, Germany), with the modification 
that 11 U of lysostaphin (Sigma) was added at the cell lysis step. DNA quantity for each 
isolation was measured using a GeneQuant II RNA/DNA Calculator (Pharmacia), and diluted 
to a concentration of 100 ng/μl with TE buffer. 
5.6.2 Molecular typing using PFGE (II-IV) 
The DNA restriction fragments were separated using PFGE procedures of Murchan et al. 
(2003). Two λ concatamer markers (NewEngland BioLabs, USA) were included in each gel 
and S. aureus NCTC 8325 was used as a migration control for normalisation in every IV-VI 
lane. 
 
PFGE fingerprints were stored and processed with Bionumerics software (Applied Maths, 
Kortrijk, Belgium, version 4.00) with Dice coefficients, using clustering by the unweighted 
pair group method with arithmetic mean. Position tolerance was set at 1.0 and cluster cut-off 
at the 80% similarity level. 
 
The relatedness of the fingerprints in studies II-IV was assessed both by using computer 
analysis (BioNumerics, Applied Maths, Kortrijk, Belgium, version 4.00) and visual 
comparison. In studies II-III, where the isolates were collected during several years from 70 
herds, the following criteria were used for determining the genetic relatedness of the different 
fingerprints in visual comparison: fingerprints with one to three band shifts were considered to 
be closely related and of the same pulsotype, and these were assigned the same capital letter; 
the closely related clones of the respective pulsotype were accordingly assigned a numeric 
suffix. Fingerprints with more than three band shifts were interpreted as being genetically 
unrelated and of a different pulsotype. In study IV, where the isolates were obtained during a 
shorter period in two herds only, the criteria of Tenover et al. (1995) were applied: PFGE 
fingerprints with more than seven band differences were considered to be unrelated and 
assigned different capital letters; patterns with one to six band shifts were assigned the same 
capital letters and were accordingly represented by a numeric suffix. 
5.6.3 Detection of genes encoding virulence and adhesion factors using polymerase chain 
reaction (III-IV) 
PCR was used to identify the genes. The primers and PCR conditions used are listed in Table 
1. In study III, multiplex PCR was conducted for the following genes sea, seb, sec, sed, see 
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(set-1), tst, mecA, eta, etb (set-2), seg, seh, sei, sej (set-3), hla, hlb (set-4), hld, hlg (set-5), sen, 
seo (set-6), and lukED, lukM (set-7). Individual PCR reactions were finally conducted for sel, 
sek, sem, and seu. In study IV, the multiplex PCRs were used for detection of sea, sec, sed 
(set-1), tst, mecA (set-2), seg, seh, sei (set-3), hla, hlb (set-4), hld, hlg (set-5), sen, seo (set-6), 
and for lukED, lukM (set-7). Individual reactions were conducted for sej, sek, sel, sem, seu, 
(III-IV), and for fnbA and fnbB (IV). Each 50-μl PCR mixture contained 2.5 U DyNAzymeTM 
DNA polymerase (Finnzymes, Espoo, Finland), 200 μM of dNTP mix, 20 pmol of each 
primer, and 100 ng of DNA template. 
 
The reactions were carried out in a Peltier 200 Thermal Cycler (MJ Research, Waltham, MA, 
USA), and each isolate was tested at least twice for each gene. The amplification products 
were analysed using electrophoresis through 1% agarose gels. A positive control (Table 1) 
and a negative control (reaction mixture without DNA template) were included in each PCR 
run.
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Table 1. Primer sequences, PCR conditions and control strains used in the thesis (studies III-IV) to 
detect gene determinants by PCR. 
Gene Primer sequence (5´-3´) Reference Conditions Control strain 
nuc GCGATTGATGGTGATACGGTI 1 1 NCTC 8325 
 AGCCAAGCCTTGACGAACTAAAGC 1   
blaZ AAG AGA TTT GCC TAT GCT TC 2 10 ATCC 29213 
 GCT TGA CCA CTT TTA TCA GC 2   
femA AAAAAAGCACATAACAAGCG 3 3 NCTC 8325 
  GATAAAGAAGAAACCAGCAG 3    
mecA ACTGCTATCCACCCTCAAAC 3 3 NCTC 8325 
  CTGGTGAAGTTGTAATCTGG 3    
sea GGTTATCAATGTGCGGGTGG 3 3 FRI 913 
  CGGCACTTTTTTCTCTTCGG 3    
seb GTATGGTGGTGTAACTGAGC 3 3 NO-50328 
  CCAAATAGTGACGAGTTAGG 3    
sec AGATGAAGTAGTTGATGTGTATGG 3 3 FRI 913 
  CACACTTTTAGAATCAACAG 3    
sed CCAATAATAGGAGAAAATAAAAG 3 3 EELA-7 
  ATTGGTATTTTTTTTCGTTC 3    
see AGGTTTTTTCACAGGTCATCC 3 3 FRI 913 
  CTTTTTTTTCTTCGGTCAATC 3    
eta GCAGGTGTTGATTTAGCATT 3 3 DK 959 
  AGATGTCCCTATTTTTGCTG 3    
etb ACAAGCAAAAGAATACAGCG 3 3 DK 880 
  GTTTTTGGCTGCTTCTCTTG 3    
tst ACCCCTGTTCCCTTATCATC 3 3 FRI 913 
  TTTTCAGTATTTGTAACGCC 3    
seg AATTATGTGAATGCTCAACCCGATC 4 41, 32 ATCC 49775 
  AAACTTATATGGAACAAAAGCTACTAGTTC 4    
seh CAATCACATCATATGCGAAACCAG 4 41, 32 ATCC 51811 
  CATCTACCCAAACATTAGCACC 4    
sei CTCAAGGTGATATTGGTGTAGG 4 41, 32 ATCC 49775 
  AAAAAACTTACAGGCAGTCCATCTC 4    
sej TAACCTCAGACATATATACTTCTTTAACG 4 41, 32 DO-204 
  AGTATCATAAAGTTGATTGTTTTCATGCAG 4    
sek TTA GGT GTC TCT AAT AGT GCC AGC 5 5 FRI 913 
 AGC TGT GAC TCC GCC ATA TAT GTA 5   
sel ATC ACA CCG CTT AGA ATA CTC 5 5 FRI 913 
 GGT ATT ATT CTT GGC GAA TCT 5   
sem TGC TAT TCG CAA AAT CAT ATC GCA ACC 5 5 ATCC 49775 
 TCA ACT TTC GTC CTT ATA AGA TAT TTC TA 5   
sen GCT TAT GAG ATT GTT CTA CAT AGC TGC 5 5 ATCC 49775 
 CAT TAA CGC CTA TAA CTT TCT CTT CAT C 5   
seo GAG AGT TTG TGT AAG AAG TCA AGT G 5 5 ATCC 49775 
 GAT TCT TTA TGC TCC GAA TGA GAA 5   
seu TAAAATAAATGGCTCTAAAATTGATGG 6 6 EELA-7 
 CGTCTAATTGCCACGTTATATCAGT 6   
lukED TGAAAAAGGTTCAAAGTTGATACGAG 4 41, 32 FRI 913 
  TGTATTCGATAGCAAAAGCAGTGCA 4 41, 32   
lukM TGGATGTTACCTATGCAACCTAC 4 
41, 32 FRI 913,  
ATCC 31890 
  GTTCGTTTCCATATAATGAATCACTAC 4 41, 32   
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Table 1. Continued 
Gene Primer sequence (5´-3´) Reference Conditions Control strain 
hla CTGATTACTATCCAAGAAATTCGATTG 4 41, 32 NCTC 8325 
  CTTTCCAGCCTACTTTTTTATCAGT 4 41, 32   
hlb GTGCACTTACTGACAATAGTGC 4 41, 32 EELA 
2285195 
  GTTGATGAGTAGCTACCTTCAGT 4 41, 32   
hlg GCCAATCCGTTATTAGAAAATGC 7 41, 32 FRI 913 
  CCATAGAYGTAGCAACGGAT 8 41, 32   
hld AAGAATTTTTATCTTAATTAAGGAAGGAGTG 4 41, 32 NCTC 8325 
  TTAGTGAATTTGTTCACTGTGTCGA 4   
fnbA GCGGAGATCAAAGACAA 9 11 CCUG 47326 
 CCATCTATAGCTGTGTGG 9   
fnbB GGAGAAGGAATTAAGGCG 9 11 CCUG 47326 
 GCCGTCGCCTTGAGCGT 9   
 
1 Brakstad et al., (1992) 
2 Vesterholm-Nielsen et al., (1999) 
3 Mehrotra et al., (2000) 
4 Jarraud et al., (2002) 
5 Smyth et al., (2005) 
6 Letertre et al., (2003) 
7 Lina et al., (1999) 
8 von Eiff et al., (2004) 
9 Nashev et al., (2004) 
10 Haveri et al., (2005) 
11 Initial denaturation step (5 min at 94ºC) followed by 30 cycles of amplification (denaturation for 
30 s at 94ºC, annealing for 30 s at 50ºC and elongation for 1 min at 72ºC) terminated with a 7 min 
incubation step at 72ºC 
41 PCR conditions described by Jarraud et al., (2002) was used in study III 
32 PCR conditions described by Mehrotra et al., (2000) was used in study IV 
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5.7 Classification of clinical severity and persistence of IMI 
Clinical signs of the individual cows in studies II-III were graded as defined by the IDF 
(1997), with the following modifications: the type of mastitis or clinical signs of the cow were 
graded as subclinical (CMT score <3, no clinical signs), mild clinical (visual abnormalities in 
milk and/or swelling, heat, redness, or tenderness in the udder), or severe clinical, if elevated 
rectal temperature (>39.0°C) and other general signs (anorexia, decreased rumen motility, and 
general attitude) were also observed. 
 
In study II, the IMI was considered persistent and to represent the same episode, if the same 
pulsotype, compared with the initial isolate was isolated during the follow-up period. The IMI 
was classified persistent when the first follow-up isolate of S. aureus was of indistinguishable 
pulsotype and virulence gene profile compared with the initial isolate (II-III), or if the same S. 
aureus pulsotype was repeatedly isolated from the same quarter during the same lactation 
(IV). Quarters healthy before the farm visit but in which S. aureus was detected later during 
the study period were defined as new infections. 
5.8 Bacteriological definitions 
Isolate was considered to represent a group of monoculture bacterial cells obtained from a 
primary colony growing on solid medium where the sample was originally inoculated. Strain 
was defined as a variant of bacterial isolate having phenotypic or genotypic properties that 
distinguished the strain from other isolates of the same species. Clonal type, genotype, and 
pulsotype were used as synonyms to indicate a group of strains most likely having a common 
ancestor, and were assigned on the basis of fingerprints obtained with PFGE typing. 
5.9 Statistical analyses 
The differences in bacterial diagnoses and resistance patterns between 1995 and 2001 were 
compared using the two-sample proportion test in Statistix (Analytical Software, Tallahassee, 
FL) (I). 
 
The effect of pulsotype on the severity of the clinical signs was tested using multinomial 
logistic regression (proportional odds model) by including time of infection (days from 
calving) in the model (II). The cows were divided into two groups according to the stage of 
lactation: days 0-30 and days > 30 post-partum. The cows were also categorised as 
primiparous and multiparous (>1 parities) according to the parity. The effects of pulsotype 
and β-lactamase production of the S. aureus isolate on persistence of infection were tested by 
logistic regression by including time of infection and severity of clinical signs into the model. 
The influence of other measured variables, such as parity and number of infected quarters, 
were preliminary screened out by Fischer’s Exact Test. The effect of pulsotype, including 
time of infection on NAGase activity was tested by two-way analysis of variance, using log-
transformed values for NAGase. One quarter value of the same cow was randomly selected 
into the analyses and this was repeated twice. The possible effect of genetic variation between 
the representative clones of pulsotype A-E on severity of signs and persistence were 
preliminary screened by Fischer’s Exact Test. The analyses were carried out with Stata 7.0 
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(Stata Statistical Software, College Station, Tex.). P values of <0.05 were considered to be 
statistically significant. 
 
The effects of each gene on the severity of the clinical signs (n=116 S. aureus isolates) was 
tested by using ordinal logistic regression (III). Pearson’s chi-square test or Fischer’s exact 
test were used to study the associations of virulence genes with persistence of IMI. The effect 
of each gene on persistence of IMI within-pulsotype was tested by using Pearson’s chi-square 
test or Fischer’s exact test. The correlation of cumulative number of virulence genes and 
severity of signs was tested using Pearson two-tailed correlation. The analyses were 
conducted with SPSS Statistical Software, version 13.0 (SPSS Inc., Chicago, Illinois). 
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6. RESULTS 
6.1 Prevalence and occurrence of Staphylococcus aureus (I, IV) 
6.1.1 In the herds included in the Finnish national mastitis survey (I) 
Staphylococcus aureus IMI was isolated in 430 (3.4%) of the 12 661 quarters of the 3270 
cows sampled in the national survey. In total 334 cows (10.2%) were positive for S. aureus, 
which was detected in 140 (64.8%) of the 216 farms. Herds with S. aureus positive cows had 
on average 17.0 cows (min. 3, max. 48) with a mean milk yield of 7670 kg per annum (min. 
5000, max. 11 000), and a mean BMSCC of 146 500 cells/ml (min. 3000, max. 578 000). The 
majority (88.6%) were housed in stanchion-barns, nine herds had warm loose-housing (6.4%) 
and seven herds (5.0%) had cold loose-housing. According to the health data of the herds, an 
average of 4.4 mastitis treatments (min. 0, max. 19) were recorded in the herds during 2000 
(Anna Pitkälä, Evira, unpublished data). 
 
Herds that were not positive for S. aureus IMI in the survey comprised on average 11.7 cows 
(min. 2, max. 32), had a mean milk yield of 7178 kg per annum (min. 2400, max. 11 200) and 
a mean BMSCC of 129 700 cells/ml (min. 20 000, max. 800 000). Seventy of the herds 
(92.1%) were housed in stanchion-barns and the remaining six herds (7.9%) had warm loose-
housing. On average 2.9 mastitis treatments (min. 0, max. 22) were recorded in these herds in 
2000 (Anna Pitkälä, unpublished data). In Table 2 characteristics of the herds grouped by 
number of cows in the herd are shown. 
 
 
Table 2. Characteristics of the Finnish survey herds with S. aureus IMIs grouped according to number 
of cows in the herd. In the second column, the proportion of S. aureus positive herds among all herds 
of the given size is shown. With permission of A. Pitkälä (unpublished data). 
No. of 
cows in 
the 
herd 
No. of 
herds with 
S. aureus/ 
all herds 
of the size 
(%) 
Mean % of S. 
aureus 
positive cows 
of all cows in 
the herd (min, 
max) 
Mean BMSCC 
cells/ml(min, max) 
Mean milk 
yield, 
kg/cow/year 
(min, max) 
Mean no. of 
recorded mastitis 
treatments during 
lactation (min, 
max) /cow in 
2000** 
1-10 32/73 
(43.8) 
1.9 (1, 6)* 154 484  
(33 000, 578 000) 
7044  
(5000, 9146) 
0.34 (0.0, 1.7) 
11-20 69/98 
(70.4) 
15.0%  
(5.0, 63.6) 
142 522  
(38 000, 440 000) 
7540  
(5000, 10 000) 
0.23 (0.0, 0.75) 
21-30 29/33 
(87.9) 
12.1%  
(3.5, 26.0) 
156 482  
(44 000, 544 000) 
8236  
(6000, 11 000) 
0.30 (0.0, 0.86) 
>30 10/12 
(83.3) 
9.4%  
(3.2, 19.4) 
135 444 
(55 000,190 000) 
8787  
(7655, 9621) 
0.032 (0.030, 0.37) 
Total 140/216 
(64.8) 
    
* Mean no. of cows with S. aureus (min-max) is shown instead of % for herds with 1-10 lactating 
cows. 
**Calculated on the basis of the number of treatments in the herd health records. 
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The proportion of quarters positive for S. aureus among those with bacterial growth is shown 
in Table 3. S. aureus was present in 22.6% of the 155 samples harbouring two bacterial 
species concomitantly, usually together with CNS. Cows with S. aureus IMI had on average 
1.28 infected quarters. Of these cows, 75.0% had one quarter, 16.5% two quarters, and 3.9% 
three quarters with S. aureus IMI. Approximately half of the quarters positive for S. aureus 
produced milk with an SCC over the threshold of 300 000 cells/ml. S. aureus IMI was slightly 
less common in cows in their first and second parities than in the older cows, but the 
difference was not statistically significant. 
 
Table 3. Bacterial isolates found during a survey of 2001. In the first column percentages of quarter 
milk samples are shown. Proportions of different pathogens are given in the second column. 
 n=12 661 n=4237 
CNS 16.61 49.63 
Staphylococcus aureus 3.40 10.17 
Streptococcus agalactiae 0.02 0.07 
Streptococcus dysgalactiae 0.05 0.14 
Streptococcus uberis 0.65 1.94 
Other streptococci 0.07 0.21 
Enterococcus spp. 0.40 1.20 
Aerococcus viridans 0.24 0.71 
Lactococcus spp. 0.24 0.73 
Corynebacterium bovis 11.52 34.41 
Coliforms 0.14 0.42 
Other bacteria 0.12 0.37 
Contaminated samples 4.15  
No bacteria 62.38  
Total 100.0 100.0 
 
6.1.2 In IMI and extramammary sites (IV) 
S. aureus IMI was detected in 26 quarters of 17 cows in Herd I, and in 11 quarters of 10 cows 
in Herd II during the study period. In Herd I, eight cows (27%) and 12 quarters (10%) had S. 
aureus mastitis during the follow-up period before the farm visit. For Herd II, the respective 
figures were five quarters (2%) in five cows (9%). 
 
At the time of the farm visit, S. aureus IMI was detected in four cows (15% of 27 cows) and 
seven quarters (7% of 108 quarters) in Herd I. Twenty-eight percent of the samples from the 
other sites harboured S. aureus (Table 4); 48% of the quarters and 85% of the cows had S. 
aureus on the teat walls, teat orifices and/or in teat canals. Presence of S. aureus in teat end 
(P<0.05) and in teat canal (P<0.01) was associated with S. aureus IMI. Eighty percent of the 
quarters that became infected with S. aureus during the study also had the bacterium on the 
teat skin and/or in teat canals, whereas for those sites on the unaffected quarters, the 
respective figure was only 42%. Skin lesions of seven cows (26%) supported growth of S. 
aureus, and two of the cows had concomitant S. aureus mastitis. In Herd II, six of the 51 cows 
(12%) had S. aureus IMI, with seven infected quarters (3%) during the farm visit. S. aureus 
was detected in 44% of samples from the other sites. Ninety-six percent of the cows and 81% 
of the quarters had the bacterium on the teat skin or in the teat canals. Presence of S. aureus in 
the teat canal was associated with S. aureus in the milk (P<0.01). Twenty-one cows had S. 
aureus in the skin lesions, four cows having concomitant S. aureus IMI. 
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During the follow-up period after the farm visit, S. aureus IMI was detected in 11 cows (37%) 
and in 14 quarters (12%) in Herd I. In Herd II, S. aureus IMI was detected in three cows (6%) 
and in three quarters (1%). 
 
Table 4. S. aureus isolated from different sample sites in Herds I and II during the farm visit. 
Sample site No. (%) of samples 
with S. aureus/ No. of 
all samples in Herd I 
No. (%) of samples 
with S. aureus/ No. of 
all samples in Herd II 
Total no. (%) of 
samples with S. 
aureus/ No. of all 
samples 
Milk 7/108 (6.5) 7/197 (3.6) 14/305 (4.6) 
Teat wall 27/108 (25.0) 131/204 (64.2) 158/312 (50.6) 
Teat orifice 27/108 (25.0) 130/192 (67.7) 157/300 (52.3) 
Teat canal 32/108 (29.6) 35/191 (18.3) 67/299 (22.4) 
Skin lesion 7/8 26/33 (78.8) 33/41 (80.5) 
Liner, before milking 2/4 0/32 (0.0) 2/36 (5.6) 
Liner, after milking 28/108 (25.9) 48/186 (25.8) 76/294 (25.6) 
Milkers’ hands 2/2 0/2 2/4 
Milkers’ nostrils 2/2 3/4 5/6 
Total 134/556 (24.1) 380/1041 (37.5) 521/1597 (32.6) 
 
6.2 Diversity of Staphylococcus aureus strain-types originating from mastitis infections 
(II-III) 
6.2.1 Diversity and distribution of pulsotypes and gene profiles 
The 217 S. aureus isolates collected from mastitis infections between September 1993 and 
January 1997 (II) comprised 32 PFGE fingerprints of 22 pulsotypes (A-V) analysed visually 
for genetic relatedness. Pulsotypes A to E were considered to consist of 2 to 5 closely related 
clones, A1-A5, B1-B2, C1-C2, D1-D2, and E1-E4. Using computer-aided analysis with an 
80% cluster cut-off value, S. aureus isolates were distributed among 25 different clusters. The 
clones of pulsotype A and B are shown in Figure 2. 
 
 
 
Figure 2. Clones of pulsotype A and B isolated in study II. From the left: control (NCTC 8325); 
pulsotype A, clones from A1 to A5; control (NCTC 8325); pulsotype B, clones B1 and B2; pulsotype 
B, clones B1 and B2; control (NCTC 8325). 
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Pulsotypes A to E were isolated from several cases of mastitis and these were considered to be 
the predominant pulsotypes. Pulsotypes F-V were each detected only once and were regarded 
as being sporadic pulsotypes. The occurrence of the different pulsotypes from 1993 to 1997 is 
presented in Figure 3. Pulsotype A and E were observed continuously and pulsotype B until 
1996. Pulsotype C and D appeared in 1994 but disappeared after 1995 and 1996. 
 
 
9796959493
year
15
12
9
6
3
0
N
 o
f h
er
d
type E
type D
type C
type B
type A
type1
 
Figure 3. Occurrence of the predominant S. aureus pulsotypes (A-E) isolated from bovine mastitis in 
various herds between 1993 and 1997 in the practice area of the Ambulatory Clinic of Helsinki 
University, in the southern Finland (II). 
 
The 116 pre-treatment S. aureus isolates represented pulsotypes A-E, F-I, K-O, R, T, or U, 
whereas pulsotypes J, P, Q, S, and V were isolated only from the follow-up samples after 
treatment. Among the 116 pre-treatment isolates, the genes hla, lukED, hlg, hld and hlb were 
the most common, being identified in 97.4%, 96.6%, 88.8%, 87.9% and 76.7% of the isolates, 
respectively. Sixty-nine percent of the isolates contained at least one SAg determinant, the 
most frequent being seo (in 44.0%), sen (39.7%), sem (36.2%), seg in combination with sei 
(31.9%), sed together with sej (19.8%) and seu (19.8%). lukM was identified in 32 isolates 
(27.6%). The genes see, eta, and etb were not detected. 
 
Forty-three virulence gene profiles were recorded. The most common combination contained 
hla, hlb, hld, hlg and lukED (n = 23), which was detected in pulsotype A (n=19), I, L, M, and 
O.  hla, hlb, hld, hlg, lukED, sed, and sej was the next most common profile, being identified 
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in pulsotype A only (n=13). hla, hld, hlg, lukED, seg, sei, sem, sen, and seo (n = 8) was 
typical of pulsotype E (n=5), and hla, hlb, hld, hlg, lukED, lukM, seg, sei, sem, sen, seo, and 
seu positive isolates (n = 7) were usually of pulsotype B (n=5). The genes seg, sei, sem, sen, 
and seo were detected concomitantly in a total of 34 isolates (29.3%), and in 14 isolates (12% 
of all) they were accompanied by seu. sec and tst were present in eight isolates, those of six 
also had sel. The genes encoding SAg accumulated in the predominant pulsotypes A-E 
(73.1% positive) and were significantly less common among the sporadic pulsotypes (33.3% 
positive) (P<0.01). Pulsotype B harboured the highest number of virulence genes, varying 
between 7 (9.1%) and 15 (45.5%). Only 56% of pulsotype A carried the genes for SAg, 
whereas pulsotype B, C, D, and E always had the genes (Figure 4). 
 
 
Figure 4. Dendrogram showing genetic similarity (%) of the pulsotypes and their clonal variants 
derived from 116 bovine S. aureus isolates at the onset of mastitis. The frequencies of genes encoding 
superantigens SAg of each pulsotype and clonal variant (A1-U) are presented. egc1 indicates the 
complete egc cluster, consisting of the genes seg, sei, sem, sen, and seo. egc2 indicates the complete 
egc cluster and seu. 
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6.2.2 Diversity within and between farms 
In 54 herds (77%) only a single pulsotype was detected. Of the 29 herds where several 
mastitis cases (2 to 6) occurred, infections were due to the same pulsotype with 
indistinguishable gene profiles in 17 herds.  In five herds several cases of mastitis were 
caused by the same pulsotype, but the number and quality of SAg genes of this pulsotype 
varied on different occasions. In six of the 12 herds where unrelated pulsotypes were found, 
the unrelated S. aureus pulsotypes caused mastitis simultaneously. The clones A1, A2, B1, 
B2, C1, C2, D1, D2, E1, and E2 of pulsotypes A-E were found in several herds. 
6.2.3 Diversity within cows 
In cows with several quarters with concomitant S. aureus mastitis, PFGE fingerprints of the 
isolates were indistinguishable and were considered to represent the same clone. In seven 
cows a new quarter was infected with S. aureus during the follow-up period, and their PFGE 
fingerprints (A, D, E) were indistinguishable from those of the initial S. aureus isolate. 
 
In 45 cows S. aureus mastitis was still detected after treatment in the same quarter. In 40 cows 
the initial S. aureus strain was found in the same quarter during the follow-up period after 
treatment. These infections were caused by pulsotype A, B, C, D, E, F, G, or R with identical 
virulence gene profiles as the initial isolate. 
6.3 Antimicrobial resistance of Staphylococcus aureus (I-III) 
6.3.1 Resistance to penicillin (I-III) 
In the mastitis survey (I), penicillin resistant (β-lactamase positive) S. aureus strains were 
isolated from 69 herds, which comprised 49.3% of the herds with S. aureus IMIs and 32.1% 
of all herds surveyed. The herds with penicillin resistant S. aureus included 18.2 cows on 
average (median 16; min 3, max 48). The general herd characteristics did not differ from the 
mean figures for all S. aureus infected herds. On average 3.2 quarters per farm (median 2.0; 
min 1, max 15) had IMI due to penicillin resistant S. aureus. Thirty-four of the herds (49.3%) 
had both penicillin resistant and penicillin susceptible strains. In those herds, on average 
56.2% (median 50.0%; min 25.0%, max 92.3%) of the quarters with S. aureus IMI harboured 
penicillin resistant strains.  More than half (52.1%) of the 196 randomly selected S. aureus 
isolates collected in the survey produced β-lactamase (I). 
 
In studies II-III, 51 of the 116 isolates (44.0%), derived from cases of mastitis prior to 
treatment, produced β-lactamase and were positive for blaZ. Such isolates were retrieved from 
34 (48.6%) of the 70 herds. The share of penicillin resistant strains was 42% for pulsotype A, 
4.5% for type B, and 100% for type E. Four of the six pulsotype D isolates were penicillin 
resistant, but none of the pulsotype C. Pulsotype A (P<0.05), D (P<0.01), and E (P<0.001) 
were significantly more often penicillin resistant compared with pulsotype B. Penicillin 
resistance was not linked with particular clonal variants of pulsotype A and D, thus, PFGE 
was unable to differentiate between the penicillin resistant and penicillin susceptible strains 
within a particular pulsotype. Among the 17 sporadic types, pulsotype F, I, K, N, R, T, and U 
were penicillin resistant. 
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6.3.2 Resistance to other antimicrobials (I) 
Resistance of S. aureus to different antimicrobials isolated in the survey is presented in Table 
5. Multiresistance (resistance to more than two antimicrobials) was found in 2.0% of the 196 
isolates tested. All of the tested isolates were susceptible to cephalotin, enrofloxacin, 
gentamycin, neomycin and spiramycin. 
 
Table 5. Antimicrobial resistance among the 196 Staphylococcus aureus isolates originating rom the 
Finnish survey herds. 
Antimicrobial  
 
Breakpoint for 
resistance 
μg/ml 
% resistant MIC50 
(μg/ml)1 
MIC90 
(μg/ml)1 
Range (μg/m) 
Clindamycin >2 0.5 1 1 1 to 4 
Erythromycin >4 1.5 0.5 0.5 0.5 to 8 
Oxacillin >2 4.12 1 2 0.5 to 8 
Oxytetracycline >8 5.1 1 1 0.5 to 128 
Penicillin3  52.1    
Streptomycin >32 4.1 4 16 1 to 256 
Trimethoprim/ 
Sulfametoxazole4 
>2 1.5 0.25 0.25 0.25 to 16 
1MIC50 and MIC90 = Minimum inhibitory concentrations at which 50 and 90% of isolates are at or 
below 
2Primary result, oxacillin susceptible according to confirmatory test 
3β-Lactamase production 
4Concentration of trimethoprim is given, tested at concentration ratio 1:19 
6.4 Relationship of Staphylococcus aureus strain-types to the inflammatory response of 
the affected quarter, clinical characteristics and persistence of mastitis (II-III) 
6.4.1 Staphylococcus aureus pulsotypes (II) 
In the 116 cows treated for S. aureus mastitis from 1993 to 1997, S. aureus mastitis occurred 
between 1 and 321 days in milk, with an average of 81 days and a median of 51 days post 
partum. Thirty-six percent of the cases were diagnosed within the first two weeks after 
calving and 43% during the first month post partum. The clinical signs of the cows were more 
severe (P < 0.05) and milk NAGase activity values were higher (P < 0.05) within the first 
month after calving than during the later lactation. The severity of the clinical signs (Table 6) 
recorded correlated with udder inflammatory response determined by milk NAGase activity. 
 
Table 6. Characteristics of 116 cases of bovine S. aureus mastitis (II). 
Severity of 
signs 
No. of 
herds 
No. of 
cows 
(quarters) 
Mean rectal 
temperature 
˚C (SE) 
Mean 
NAGase 
U/ml 
(SE) 
Pulsotype of the infecting strain 
(No. of cows) 
Subclinical 25 34 (39) 38.3 (0.11) 146 
(26.7) 
A (15), B (2), C (5), E (6), H (1), 
K (1), O (1), R (1), U (1) 
Mild 
clinical 
41 53 (62) 38.8 (0.067) 350 
(29.6) 
A (23), B (8), C (3), D (5), E (11), 
F (1), L (1), M (1), N (1) 
Severe 
clinical 
27 29 (33) 40.1 (0.11) 460 
(36.6) 
A (12), B (12), D (1), E (1),  
G (1), I (1), T (1) 
All 70 116 (134) 39.4 (0.10) 323 
(21.5) 
A (50), B (22), C (8), D (6),  
E (18), F-U (1 each) 
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Association between pulsotype, severity of clinical signs and milk NAGase activity was 
tested for strains of pulsotypes A, B, C, D and E (n=104 strains). Infections caused by 
pulsotype B were related with more severe signs. Compared with this genotype, mastitis 
caused by pulsotype A (P<0.05), pulsotype C (P<0.01), or pulsotype E strains (P<0.05) were 
significantly less likely to be associated with increased severity of mastitis. Milk NAGase 
activity levels of quarters with mastitis caused by pulsotype B strains were significantly 
higher (mean, 427 to 441 U/ml; SE 45.7-48.0) compared with those from mastitis caused by 
pulsotype C (mean, 124 to 127 U/ml; SE 27.0-28.2) (P < 0.05), and they tended to be higher 
than those associated with pulsotypes A (mean, 307 to 317 U/ml; SE 32.5-33.3) (P 0.05) and 
E (mean, 282 to 307 U/ml; SE 46.0-54.6). The NAGase activity values associated with 
pulsotype D (mean, 420 to 433 U/ml; SE 60.5-62.8) were close to those for pulsotype B 
strains. 
 
For pulsotypes A, B, C, D and E (No. of strains=97), persistent mastitis caused by pulsotype 
A (P<0.01; OR 23.1; 95% CI for OR 2.8-190.9), pulsotype C (P<0.05; OR 22.9; 95% CI for 
OR 1.8-288.7), pulsotype D (P<0.01; OR 41.9; 95% CI for OR 2.9-598.6) and pulsotype E 
(P<0.01; OR 2.4; 95% CI for OR 2.4-227.7) was significantly more common compared with 
pulsotype B, which were eliminated from the quarters almost always. Twenty cows (40%) 
infected with pulsotype A, 13 (59%) with pulsotype B, 2 out of the six cows infected with 
pulsotype C, and 8 cows (44%) infected with pulsotype E were all diseased within one month 
from calving. Mastitis due to pulsotype C was detected only during later lactation.  
6.4.2 Staphylococcus aureus pulsotypes and virulence gene profiles (III) 
The follow-up data were complete and persistence of mastitis could be assessed in 106 of the 
116 cows. However, in five cows, the same pulsotype was isolated from the quarter but the 
gene profiles differed from those of the original strains. These cases were excluded from the 
analyses. Finally, persistent mastitis developed in 40 cows and was eliminated from 61 cows. 
Severity of clinical signs and persistence of mastitis caused by different S. aureus pulsotypes 
is shown in Table 7. 
 
 
Table 7. Severity of clinical signs and persistence of mastitis caused by different Staphylococcus 
aureus pulsotypes (PT). Clinical signs were determined for 116 cows and persistence status for 101 
cows. 
   Signs of mastitis Persistence status 
PT Herds Cows 
(quarters) 
Subclinical Mild Severe Recovered Persistent ND 
A 34 50 (57) 15 23 12 22 24 4 
B 19 22 (25) 2 8 12 20 1 1 
C 3 8 (10) 5 3 0 4 3 1 
D 4 6 (8) 0 5 1 2 3 1 
E 12 18 (20) 6 11 1 7 6 5 
F-I, K-
O, R, 
T, U* 
12 12 (14) 5 4 3 6 3 3** 
Total  116 (134) 33 54 29 61 40 15 
*ND, not determined 
** Three quarters of one cow were infected with pulsotype H 
**Persistence status for strains of pulsotypes I, T and U not determined. 
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The genes for SAg were present in 80.0% of isolates from persistent mastitis, as opposed to 
63.9% of those from non-persistent mastitis. The difference was significant (31/39 vs 19/41; 
P<0.01) after exclusion of pulsotype B strains, which were nearly always eliminated. 
Pulsotype A carried most of the genes sed and sej (21 of 23), which were associated with 
persistent mastitis (Table 8). The link between non-persistent IMI and the genes seg, sei, sem, 
seo, seu, and lukM ceased to exist if pulsotype B, which usually carried these genes, were 
excluded. Thereafter lukM positive strains tended to dominate in moderate and severe clinical 
mastitis (in 9 of 10 cases), but IMI seemed to persist more often than in cases caused by lukM 
negative isolates. The positive correlation recorded between the cumulative number of 
virulence genes and the severity of clinical signs (0.215; P<0.05) was not statistically 
significant in the absence of pulsotype B. 
 
 
Table 8. Virulence genes in Staphylococcus aureus isolated from 116 cows with different clinical 
signs of mastitis prior to treatment. Possible persistence of mastitis was determined for 101 cows. 
 
 
 
Severity of signs (116 cows) 
 
Persistence of IMI (101 cows)a 
Gene Subclinical 
(n=33) 
Mild 
(n=54) 
Severe 
(n=29) 
Recovered 
(n=61) 
Persistent 
(n=40) 
sea 3 (9.1%) 4 (7.4%) 0 2 (3.3%) 4 (10.0%) 
seb 1 (3.0%) 0 0 0 1 (25.0%) 
sec 2 (6.1%) 4 (7.4%) 3 (10.3%) 9 (14.8%) 0* 
sed, sej 6 (18.2%) 11 (20.4%) 6 (20.7%) 5 (8.2%) 17 (42.5%) ** 
seg, sei 6 (18.2%) 21 (38.9%) 10 (34.5%) 23 (37.7%) 8 (20.0%)* 
seh 5 (15.1%) 2 (3.7%) 0 4 (6.6%) 3 (7.5%) 
sek 4 (12.1%) 2 (3.7%) 0 2 (3.3%) 4 (10.0%) 
sel 0 3 (5.6%) 3 (10.3%) 6 (9.8%) 0 
sem 7 (21.2%) 24 (44.4%) 11 (37.9%) 25 (41.0%) 9 (22.5%)* 
sen 7 (21.2%) 26 (48.1%) 13 (44.8%) 28 (45.9%) 10 (10.0%)* 
seo 8 (24.2%) 27 (50.0%) 16 (55.2%) 30 (49.2%) 13 (32.5%)* 
seu 2 (6.1%) 8 (14.8%) 13 (44.8%) 19 (31.1%) 2 (5.0%)** 
tst 1 (3.0%) 4 (7.4%) 3 (10.3%) 8 (13.1%) 0* 
lukE-D 32 (96.7%) 51 (94.4%) 29 (100.0%) 61 (100.0%) 36 (90.0%) 
lukM 3 (9.1%) 13 (24.1%) 15 (51.7%) 23 (37.7%) 5 (15.0%)** 
α 32 (97.0%) 53 (98.1%) 28 (96.7%) 59 (96.7%) 39 (97.5%) 
β 25 (75.6%) 39 (72.2%) 25 (86.2%) 48 (78.7%) 29 (72.5%) 
δ 29 (87.9%) 48 (88.9%) 24 (82.8%) 54 (88.5%) 34 (85.0%) 
γ 27 (81.8%) 47 (87.0%) 27 (93.1%) 55 (90.2%) 35 (87.5%) 
a Differences in occurrence of genes between non-persistent and persistent mastitis. 
* P<0.05 
** P<0.01 
6.4.3 The role of Staphylococcus aureus pulsotypes, virulence gene profiles, and 
penicillin resistance in persistent mastitis (III) 
The blaZ gene was detected in 51 isolates (44.0%). The gene was present as often in S. aureus 
strains causing subclinical mastitis (in 15 of 33; 45.5%) as in those strains causing clinical 
mastitis (in 36 of 83; 43.3%). blaZ was detected in 57.4% of the isolates with genes for SAg, 
but in only 13.9% of the isolates negative for those genes (P < 0.01). Twenty-three of the blaZ 
positive strains (45.1%) contained sed and sej; seo was detected in 26 (51.0%), and sem and 
sen in 23 strains (45.1%). All isolates with sed and sej also had blaZ. Among the 65 blaZ 
negative strains (56.0%), seo was detected in 25 (38.5%), sen in  23 (35.4%), seu in 22 
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(33.8%), and sem in 19 strains (29.2%). The blaZ gene was not detected together with sec, sel, 
tst, and seu, the genes characteristic of pulsotype B (95.0% blaZ negative) or with seh and 
sek, which were only found from pulsotype C (always blaZ negative). 
 
Persistent mastitis was significantly more commonly caused by blaZ positive (61.0% 
remained persistent) than blaZ negative (25.0%) S. aureus strains (P<0.01). Among the blaZ 
positive strains, persistence was significantly more common (P<0.05) if the infecting isolate 
had sed, sej, and blaZ (17/22; 76.2% persistent) than blaZ only (9/20; 45.0% persistent). 
When the isolates positive for sed, sej, and blaZ were excluded, elimination rates from 
mastitis caused by blaZ positive strains were still lower (42.1% remained infected) than those 
caused by blaZ negative strains (25.0% remained infected), but the difference was not 
significant (P=0.15). Within pulsotype A, the most common pulsotype, 15 of the 24 strains 
from persistent mastitis carried sed, sej, and blaZ, whereas only five out of 22 strains from 
non-persistent mastitis had them (P<0.01). Treatment response to amoxycillin clavulanate and 
cloxacillin was lower for blaZ positive strains of pulsotype A (10/13 and 7/8 remained 
infected) compared with blaZ positive pulsotype E strains (2/4 and 5/9 remained infected). 
6.5 Staphylococcus aureus strain types in IMI and extramammary sites (IV) 
PFGE typing produced nine fingerprints, which were classified as pulsotypes A1-G. The 
occurrence of the pulsotypes in different sample sites in Herd I and II is shown in Table 9 and 
10. 
 
 
Table 9. Staphylococcus aureus isolates and their PFGE types according to the origin of isolates in 
Herd I. 
Origin No. of samples with S. 
aureus of total No. of 
samples (%) 
No. of PFGE-
typed S. aureus 
isolates (%) 
PFGE type (n) 
Milk 37a (ND*) 
 
38 (100) A1 (27), B (10), A1+B (1) 
Teat wall 27/108 (25) 9 (33) A1 (7), B (1), A1+B (1) 
Teat orifice 27/108 (25) 13 (48) A1 (10), B (3) 
Teat canal 32/108 (30) 14 (44) A1 (11), B (3) 
Skin 7/8 (88) 7 A1 (1), B (5), A1+B (1) 
Liner before milking 2/4 2 A1 (2) 
Liner after milking 28/108 (26) 12 (43) A1 (11), B (1) 
Milkers’ hands 2/2 2 A1 (2) 
Milkers’ nostrils 2/2 2 A1 (1), C (1) 
Total 165 99 (ND) A1 (72), B (23), A1+B (3),  
C (1) 
aIncludes follow-up samples taken after treatments. 
*ND = Not determined 
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Table 10. Staphylococcus aureus isolates and their PFGE types according to the origin of isolate in 
Herd II. 
Origin No. of samples with S. 
aureus of total no. of 
samples (%) 
No. of PFGE-
typed isolates (%) 
PFGE type (n) 
Milk 21a (ND*) 21 (100) D (17), F (2), A2 (1), E2 (1) 
Teat wall 131/204 (64) 43 (34) D (38), E1 (2), A2 (1), B (1), 
F (1) 
Teat orifice 130/192 (68) 37 (28) D (33), F (2), A2 (1), B (1) 
Teat canal 35/191 (18) 20 (57) D (16), B (2), A2 (1), F (1) 
Skin 26/33 (79) 26 (100) D (24), E1 (1), F (1) 
Liner before milking 0/32 0 0 
Liner after milking 48/186 (26) 40 (83) D (38), B (1), E1 (1), 
Milkers’ hands 0/2 0 0 
Milkers’ nostrils 3/4 3 D (2), G (1) 
Total 390 190 (ND) D (168), F (7), B (5), A2 (4), 
E1 (4), E2 (1), G (1) 
aIncludes follow-up samples taken after treatments. 
*ND=Not determined 
 
 
Pulsotype A1 caused mastitis in 13 cows (19 quarters). In six of those cows (8 quarters), the 
same pulsotype was detected several times in the same quarter, indicating persistent IMI. 
Pulsotype A1 predominated in samples from the extramammary sites (Table 9) and was 
detected in 90% of S. aureus positive cows. Pulsotype A1 was present in the teat skin and/or 
teat canal in six cows without S. aureus IMI. Pulsotype B caused mastitis in eight cows (8 
quarters). At the time of the farm visit, pulsotype B was isolated in the extramammary sites in 
three healthy cows. Pulsotype B was common in the skin lesions. Indistinguishable pulsotypes 
were isolated from quarter milk and teat skin and/or canal in the same cows. The same 
pulsotype was found from skin lesions and from milk of the same cows. In two cows, 
pulsotypes A1 and B were isolated in milk of different quarters at the same time. One cow 
harboured pulsotype A1 and B in the milk of the same quarter. 
 
Pulsotype D was continuously isolated from milk in Herd II. It caused mastitis in seven cows 
(eight quarters) and was isolated several times in the milk of three cows. At the farm visit, 
pulsotype D was present in the extramammary sites in 41 cows. Two preparturient heifers 
sampled had pulsotype D in the colostrum and on the teat skin and all three heifers had it on 
the skin lesions. Pulsotype F was found together with pulsotype D in the extramammary sites 
in four cows and pulsotype E1 in three. In one cow, pulsotype F was repeatedly isolated from 
the same mastitis quarter. Pulsotypes A2, B, and E2 were sporadic; each of them were 
isolated in single cows. Six cows had S. aureus of unrelated pulsotype in the milk compared 
with the teat skin or the teat canal of the same quarter, but the pulsotype found in milk was 
also present on the skin of another quarter. The same pulsotype D was found from skin 
lesions and from milk in the same cows. Two cows had pulsotype D in the teat canal and teat 
skin, and these quarters developed mastitis caused by that pulsotype after the sampling day. 
 
Approximately one-fifth of the milking liners were contaminated by S. aureus after milking in 
both herds. In Herd II, among the 40 PFGE-typed S. aureus isolated from the liners, only one 
S. aureus strain appeared to originate from infected quarter milk; the other strains probably 
originated from teat skin and teat canals of the quarters of healthy cows. In Herd I, two liners 
were already contaminated with S. aureus prior to milking, when the origin of S. aureus in 
these liners remained undetermined. 
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In 25 samples, variation in colony morphology, colour, or haemolysis was visually detected. 
To examine whether the colony variants represented different pulsotypes, two colonies from 
each of these samples were PFGE-typed. Except for three samples in Herd I (milk, teat skin, 
skin lesion; Table 3), each sample had only one pulsotype. 
 
Variations in the gene profiles were recorded among the most common pulsotypes, A1, B, 
and D. The individual genes and the different gene profiles associated with multiple S. aureus 
isolates were not linked with the origin of the isolate. The pulsotypes and the gene profiles are 
shown in Figure 5. In Herd I, pulsotype A1 from the cows and the milking liners (n=72) had 
hla-hlg, lukED, fnbA, and fnbB and with one exception, blaZ, sed, and sej, but seldom lukM 
(n=8), and only once sem and seo. Pulsotype A1 from milkers’ hands (n=2) and nostrils (n=1) 
were positive for hla-hlg, lukED, fnbA, fnbB, blaZ, sed, and sej, as pulsotype A1 from the 
cows. In Herd II, pulsotype D strains harboured hla, hld, hlg, fnbA, and fnbB and 103 had 
lukED, but only a few were positive for lukM (n=4), blaZ (n=3), seg and sei (n=2), sed (n=1), 
sem (n=1), or seo (n=1). Pulsotype D found in the nostrils of two milkers was positive for hla, 
hld, hlg, lukED, lukM, fnbA, and fnbB. 
 
Figure 5. Dendrogram showing the numbers and the genetic relatedness of pulsotype A1-G detected in 
Staphylococcus aureus isolates originating from Herds I and II between October 2002 and August 
2003. The frequencies of the different genes for each pulsotype are presented. 
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7. DISCUSSION 
7.1 Prevalence and occurrence of Staphylococcus aureus 
Considerable efforts have been made to control bovine mastitis in Finland since the late 
1980s. The measures used have largely been successful. Regular nationwide monitoring of 
bovine mastitis demonstrates that mastitis incidence declined from 48% during the first 
survey, carried out in 1995 to 31% in 2001 (I). The control measures, including intensified 
culling of S. aureus-infected cows, have also contributed to reduction in the prevalence of S. 
aureus in Finland, which decreased from 5.1% (1988) to 3.5% (1995). In 1980, the National 
Veterinary and Food Research Institute reported S. aureus in about 50% of the milk samples 
from subclinical and clinical mastitis cases sent to the laboratory, but in 1989 this fell to 25% 
(Myllys, 1995). Measures implemented to control mastitis have almost eradicated Str. 
agalaciae, another contagious mastitis pathogen, from Finland (I). However, S. aureus has 
remained a significant mastitis pathogen. The same phenomenon was recently reported in a 
Norwegian national mastitis survey, where S. aureus was frequent but Str. agalaciae was not 
isolated at all (Østerås et al., 2006). Although the proportion of S. aureus among bacterial 
isolations declined from 16.7% to 10.2% during the past decade, both quarter (3.5-3.4%) and 
cow prevalence (10.1-11.1%) of S. aureus IMI in Finland has remained nearly stable (Myllys 
et al., 1998; study I). Bacterial growth was detected in 33.5% of milk samples, which is 
significantly more than in 1995 (21.0%; P<0.01). S. aureus is still the most common pathogen 
isolated from milk samples from clinically mastitic cows in Finland (in 18.3%) and the 
second commonest microorganism in subclinical mastitis samples (17.7%) (Koivula et al., 
2007). This implies that measures applied to prevent and control S. aureus IMI in Finnish 
dairy herds have not been sufficient to eradicate S. aureus. Multiple reservoirs and routes of 
transmission of S. aureus exist. 
 
Nationwide studies of mastitis prevalence, including prevalence of S. aureus IMIs, are few in 
number and differences are apparent between studies. For example, those regarding selection 
of samples, culture techniques and microbiological criteria. Based on the results available, S. 
aureus is one of the most common mastitis pathogens in many countries. In the Norwegian 
national mastitis survey, which included a random sample from all dairy herds, S. aureus was 
found in 8.2% of the quarters with bacterial growth (Østerås et al., 2006). The detection limit 
for S. aureus (100 cfu/ml of milk) was lower than in our survey (500 cfu/ml of milk), and the 
authors estimated that by restricting the positive findings to samples with > 1500 cfu/ml of S. 
aureus, the prevalence would have been 4.3% (Østerås et al., 2006). In the Netherlands S. 
aureus was the most common pathogen, being isolated from 16% of the subclinically infected 
quarters with milk SCC>250 000 cells/ml (Poelarends et al., 2001). During 1987-1996, S. 
aureus was reported in 41.2-39.8% of subclinically and in 33.1-26.1% of clinically infected 
quarters in Swiss cows (Schällibaum, 1999). In Brandenburg, Germany, S. aureus was one of 
the three most common pathogens after coagulase-negative staphylococci (9.1%) and 
Corynebacterium bovis (7.3%), being isolated from 5.7% of quarters with subclinical IMI 
(Tenhagen et al., 2006). In Flanders, Belgium, S. aureus was isolated from 25% of culture-
positive milk samples, other staphylococci (non-aureus staphylococci) being predominant 
(41.1%) (Piepers et al., 2007). 
 
Being a transmissible mastitis bacterium, S. aureus represents a risk for mastitis outbreaks 
occurring in a herd (Smith et al., 1998; Smith et al., 2005a), and it is important to monitor 
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herds where S. aureus frequently causes IMI. S. aureus has been isolated from the majority of 
dairy herds in many locations. S. aureus was isolated from two-thirds of herds surveyed in 
Finland (I). In Ontario, Canada, S. aureus-infected cows were detected in 92% of the herds 
(Kelton et al., 1999). On Prince Edward Island, Canada, S. aureus was recorded in 70% of the 
herds studied by Keefe et al. (1998). In the same area, at least 74% of the herds probably had 
at least one cow with S. aureus IMI, as estimated by analysis of three bulk milk cultures taken 
at weekly intervals (Olde Riekerink et al., 2006). In Lombardia, Italy, S. aureus was less 
prevalent, being found in bulk tank milk in about 30% of 1431 dairy herds investigated 
(Piccinini et al., 2003b). 
 
The increase of the incidence of S. aureus mastitis decades ago in Finland was suggested to 
be connected with the introduction of machine milking.  The pathogen was typical of small 
herds housed in stanchion-barns (Myllys, 1995a). In the present survey (I), S. aureus was 
most frequent in the smallest herds (1-10 cows), but it was also common in larger herds. It 
was found in 10 of the 12 herds with >30 cows, indicating that it has the potential to cause 
problems in herds of all sizes. The predisposing factors for S. aureus IMIs can vary according 
to herd size. In the smallest herds, even a cow with chronic S. aureus mastitis is more likely to 
stay in the herd; farmers of the small herds may be reluctant to cull cows and tend to use 
treatments more often than those with larger herds (I). In a Swedish study, changing the 
housing system from traditional tie-stalls to loose-housing decreased the incidence of clinical 
mastitis and teat injuries (Hultgren, 2002). Teat injuries have been shown to predispose 
quarters to IMI with S. aureus (Myllys et al., 1994b). Olde Riekerink et al. (2006) associated 
S. aureus more with stanchion-barn herds than with loose-housed herds. Based on this 
literature it is suggested that the problem with S. aureus mastitis may be more typically 
associated with stanchion-barn housing. 
 
In accordance with many studies (Davidson et al., 1961; Matos et al., 1991; Roberson et al., 
1994, Roberson et al., 1998; Jørgensen et al., 2005a) S. aureus was common in the 
environment and body sites of dairy cows, including non-mastitic cows (IV). The majority of 
the cows in the herds of study IV had the pathogen, but in some herds S. aureus has been 
unusual in samples other than milk (Smith et al., 2005a). The prevalence of S. aureus in dairy 
cow body sites can differ markedly even between the herds with the same prevalence of S. 
aureus IMI (Capurro et al., 2008), and may depend on several herd- and study-associated 
factors. S. aureus was a frequent finding from the teat skin and colostrum in heifers before 
calving (IV), in agreement with Roberson et al. (1994). These authors demonstrated that in 
herds with a high prevalence of S. aureus IMI (>10%) a significantly higher proportion of 
heifers carried the microorganism in epidermal and mucosal sites, compared with in the low 
prevalence (<3%) herds. Hock wounds and teat traumas were mostly contaminated by S. 
aureus (IV), which has been also shown by several authors (Larsen et al., 2000a; Jørgensen et 
al., 2005a; Capurro et al., 2008). In these sites, the pathogen can be present in high numbers 
(Myllys et al., 1994b). 
7.2. Diversity and distribution of Staphylococcus aureus strain-types 
In this thesis S. aureus isolates are differentiated on the basis of three characteristics: 
penicillin susceptibility (I-IV), PFGE type (II-IV), and genetic profile determined with PCR 
(III-IV). Although different tests were used for determining penicillin susceptibility, the 
results can be considered comparable as nitrocefin test results are highly correlated with the 
presence of the blaZ gene (Haveri et al., 2005; Pitkälä et al. 2007). 
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Using PFGE typing, the isolates were distributed among predominant and sporadic types (II, 
IV). The diversity among the PFGE types was high (II), in agreement with Joo et al., (2001), 
Middleton et al., (2002a), and Lim et al., (2004). However, as reported by numerous authors 
(Akineden et al., 2001; Stephan et al., 2001; Cabral et al., 2004; Mørk et al., 2005; Anderson 
et al., 2006; Hata et al., 2006; Aires-de-Sousa et al., 2007; Rabello et al., 2007), a few 
genotypes were responsible for a large proportion of the mastitis cases (II-IV). These 
predominant mastitis-causing genotypes can be distributed nationwide (Buzzola et al., 2001; 
Mørk et al., 2005). The differences in sampling methods and variable criteria used for typing 
likely affect the genotype diversity between studies (Joo et al., 2001; Zadoks et al., 2000; 
Middleton et al., 2002a; Zadoks et al., 2002). In studies II and III, the clones of some 
pulsotypes were recovered during several years from numerous herds, being probably 
epidemiologically unrelated. In that case, MLST would have been useful complementary 
method for epidemiological analysis. 
  
The diversity and characteristics of S. aureus strain types in a herd can be influenced by the 
herd size, introduction of new strains e.g. by purchased cows (Middleton et al., 2002b; study 
IV), milking personnel (Larsen et al., 2000a; Zadoks et al., 2002; study IV), and the selective 
pressure created by management (Sommerhäuser et al., 2003; study IV) and treatment 
practices (IV). Among S. aureus strains in a farm, those becoming predominant can be better 
adapted for survival in the hostile circumstances compared with the sporadic strains. In a 
study on human MRSA, two epidemic strains were demonstrated to survive three months 
longer and in up to 1000 times higher numbers than sporadic strains (Papakyriacou et al., 
2000). In herds where there is effective control of contagious mastitis, several atypical S. 
aureus strains started to cause mastitis (Sommerhäuser et al., 2003). Those strains were 
shown to have a low capacity for cow to cow spread and were difficult to eradicate using 
routine measures to control contagious mastitis in the herds (Sommerhäuser et al., 2003). The 
possible reasons for predominance of a particular strain in one herd and only sporadic 
appearance of the same strain in another herd (Peles et al., 2007; study IV) need to be studied 
further. 
 
In individual cows, concomitantly infected quarters and subsequent IMI in the same or new 
quarters, seem mostly to be due to the same S. aureus strains (II, IV). Repeated isolation of 
the same S. aureus strain from the same quarter most likely indicated persistence of the 
original strain because the affected quarter was continuously inflamed as indicated by 
elevated concentrations of inflammatory indicators in the milk. Myllys et al. (1997) 
demonstrated persistence of S. aureus in the mammary gland by RAPD-typing isolates 
obtained from pre-and post-treatment samples. The possibility of reinfection by a strain from 
teat skin or teat canals cannot be excluded as the strains isolated from the milk of infected 
quarters were, in most cases, indistinguishable from those present on the teat walls, teat ends 
and in teat canals (IV). With three exception, the majority of the samples harboured only one 
S. aureus genotype (II-IV). Young et al. (2001) demonstrated experimentally that individual 
quarters were colonised by more than one S. aureus strain at the same time. Recently, Smith 
et al. (2005a) observed multiple strains from single quarters in a natural infection. Human 
nasal S. aureus carriers have been shown to favour colonisation by one S. aureus strain only. 
In an experiment, where the carriers were artificially inoculated with a mixture of S. aureus 
strains including the original strain, the majority of the carriers became positive for their 
original resident strain (Nouwen et al., 2004).  
 
The selection of specific strains or clones involved in antimicrobial resistance like MRSA has 
been shown in human studies (Larsen et al., 2007). Vintov et al. (2003) demonstrated reduced 
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phage diversity and reduced number of phage groups in the countries with high occurrence of 
penicillin resistant strains. Associations between PFGE type and antimicrobial susceptibility 
profile has been recently documented (Cabral et al., 2004; Anderson et al. 2006). These 
reports are consistent with our findings, where significant differences were observed between 
pulsotypes and penicillin resistance (II-III). However, the penicillin resistant and penicillin 
susceptible strains of particular pulsotype were not differentiable by PFGE typing (II-IV). 
 
Forty-three virulence gene profiles were determined in S. aureus isolates originating from 
mastitis infections (III). The genes for haemolysins and lukED were identified in the majority 
of the isolates, but the other genes were more or less pulsotype-linked (Figure 4). The genes 
for SAg were more frequent (69% positive) than in studies of Fueyo et al. (2005) (48%) and 
Smyth et al. (2005) (45.5%) but less prevalent than reported by Srinivasan et al.  (2006) 
(93.6%). Nearly 70% of the 116 isolates harboured at least one gene encoding SAg (III). The 
genes of SAgs are known to reside in mobile clusters or pathogenicity islands (Zhang et al., 
1998; Fitzgerald et al., 2001; Jarraud et al., 2001). In agreement with previous studies (Fueyo 
et al., 2005; Smyth et al., 2005), the seg, sei, sem, sen, and seo genes, characteristic of the egc 
cluster (Jarraud et al., 2001), were the most common SAg genes. As the genes of the egc 
cluster seem to exhibit the widest distribution among different pulsotypes (Fueyo et al., 2005; 
studies III-IV), horizontal transfer of these genes appears to be common. The variation in the 
egc genes was higher in study III than reported earlier (Fueyo et al., 2005; Smyth et al., 2005). 
In agreement with the results of Becker et al. (2004), these genes do not always co-exist and 
may appear in various combinations in different S. aureus genotypes (III-IV). Isolates 
carrying sec, sel, and tst of SaPIbov (Fitzgerald et al., 2001) often also have egc and seu 
(Fueyo et al., 2005; studies III-IV). It is possible that unique pulsotypes have a selective 
system that accepts integration of only particular genes or gene clusters. 
7.3. Resistance of S. aureus to penicillin and other antimicrobials 
Antimicrobial susceptibility of mastitis pathogens, including S. aureus, has been studied 
extensively (Owens et al., 1997; Salmon et al., 1998; Gentilini et al., 2000; Werkentin et al., 
2001; Erskine et al., 2002; Gianneechini et al., 2002; Rossitto et al., 2002; Guérin-Faublée et 
al., 2003; Makovec and Ruegg, 2003; Tenhagen et al., 2006; Østerås et al., 2006). Many 
countries regularly monitor resistance of animal pathogens, including mastitis-derived S. 
aureus (DANMAP, FINRES, MARAN, NORMVET, SVARM). There seem to be regional 
differences in the resistance patterns of S. aureus (Myllys et al., 1998; Salmon et al., 1998; de 
Oliveira et al., 2000; Orchoa-Zarzosa et al., 2008), but in most countries penicillin resistance 
is the commonest form of antimicrobial resistance. Based on the results of current survey (I) 
and previous studies from Argentina, Belgium, Brazil, Finland, Germany, Great Britain 
(England), Ireland, Portugal, Switzerland, the United States and Uruguay (Devriese et al., 
1997; Gentilini et al., 2000; de Oliveira et al., 2000; Erskine et al., 2002; Gianneechini et al., 
2002; Makovec and Ruegg, 2003; Tenhagen et al., 2006; Nunes et al., 2007; Rabello et al., 
2007), approximately one-third to two-thirds of bovine S. aureus isolates are resistant to 
penicillin. Markedly lower figures were reported from Denmark, the Netherlands, Norway 
and Sweden, where only 7-23% of S. aureus isolates were penicillin resistant (SVARM, 2001; 
SVARM, 2002; DANMAP, 2003; MARAN, 2003; Bengtsson et al., 2005; NORM-VET, 
2005; Østerås et al., 2006). Resistance to oxytetracycline is the next commonest form of 
resistance, the proportion of resistant isolates usually ranging from 5% (I) to 23% (Makovec 
and Ruegg, 2003), but reaching 58% in Italy (Moroni et al., 2006). In Norway, less than 1% 
of S. aureus samples isolated from mastitis were resistant to oxytetracycline (NORM-VET, 
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2005), thus the resistance figures from different countries can considerably vary, from very 
low to very high, probably reflecting the use of antimicrobials in those countries. 
 
Antimicrobials available for treating S. aureus mastitis in different countries are likely to 
affect the panel of the tested substances, which tends to vary among studies. Estimation of 
resistance to penicillin, for example, is not reliable if only MIC for aminopenicillins and 
cephalosporins are tested (Tenhagen et al., 2006), without data on β-lactamase production. 
The methods may not be comparable, as for example correlation between the disk diffusion 
method and MIC determination by the dilution method was shown to be weak for many 
microorganims (Kibsey et al., 1994; Kelly et al., 1999). The breakpoints used to categorise 
veterinary pathogens, including bovine S. aureus, into susceptible or resistant classes should 
be specific for that use and not be adopted from human microbiology, but specific breakpoints 
are not available for all substances. 
 
The proportion of penicillin resistant, β-lactamase producing S. aureus increased markedly in 
Finland from 1988 (32.1%) to 1995 (50.7%) and remained almost stable after that (52.1% in 
2001; study I). Studies from the US reported a declining proportion of penicillin resistant S. 
aureus isolates during the last decade, using a disk diffusion method (Erskine et al., 2002; 
Makovec and Ruegg, 2003). Because the method has its limitations and β-lactamase 
production of the isolates was not tested, the results are not comparable with ours. 
 
In other Nordic countries the proportion of penicillin-resistant S. aureus has been found to be 
much lower than in Finland, 6.7% for S. aureus originating from clinical mastitis in Sweden 
(Bengtsson et al., 2005), 11% for isolates from subclinical mastitis in Norway (Østerås et al., 
2006) and 23% for mastitis isolates from Denmark (DANMAP, 2003). Explanations for the 
high prevalence of penicillin resistant S. aureus in Finland are open to discussion. The rapid 
increase of penicillin resistance of S. aureus in the 1980s in Finland was suggested to be due 
to the routine use of broad-spectrum antimicrobials in mastitis therapy (Myllys et al., 1998). 
In Norway and Sweden with lowest figures for penicillin resistance, mainly penicillin G has 
been used in mastitis therapy (NORM-VET 2005). However, since the 1990s the use of 
antibiotics in mastitis treatment has decreased markedly in Finland (FINRES-Vet, 2005-
2006). Penicillin resistance of mastitis-causing CNS, which may also function as a reservoir 
for resistance determinants (Couto et al., 1996), has not increased in relation to that of S. 
aureus (I). No within-farm correlation between penicillin resistance of S. aureus and CNS 
isolates was found in the survey of 1995 (Myllys et al., 1998). 
 
Guidelines for prudent use of antimicrobials in the treatment of animal infections, including 
bovine mastitis, to control antimicrobial resistance, have been published in Finland (Anon., 
2003). In these guidelines it is recommended that treatment of mastitis should be based on 
testing of the antimicrobial susceptibility of the causal agent. In routine diagnostics this is 
normally limited to testing of β-lactamase production of staphylococci by a nitrocephin test 
(Pitkälä et al., 2007). As a possible consequence of changes in the treatment strategies, 
multiresistance (resistance to more than two antimicrobials) of S. aureus has become less 
common in Finland (2.0% in the survey in 2001, study I) than reported in the earlier survey of 
1995 (3.2%). Resistance to oxytetracycline among S. aureus isolates decreased significantly 
from 1995, and resistance to first generation cephalosporins was not recorded at all in 2001 
(I), as compared with 2% in 1995. In general, resistance of S. aureus to other antimicrobials 
than penicillin G is at a lower level in Finland as in many other countries (de Oliveira et al., 
2000; MARAN, 2003; Moroni et al., 2006) 
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Penicillin resistance in Sweden was higher in S. aureus isolates from subclinical or chronic 
mastitis (18%) compared with isolates from clinical mastitis (6.7%) (Bengtsson et al., 2005). 
Consistent findings have been reported in Finland, where only 25% of isolates from clinical 
mastitis in the national resistance monitoring data (FINRES-Vet, 2005-2006) were resistant to 
penicillin. This is only half the figure reported for isolates from subclinical mastitis in the 
survey (I). In mastitis surveys with random sampling from all dairy herds, S. aureus isolates 
represent subclinical and chronic mastitis and resistance figures can be assumed to be higher 
than in clinical data. Specific S. aureus strains tend to be more often involved in subclinical or 
chronic mastitis than in clinical mastitis (II-III) and the resistance figures may vary between 
strains. 
 
It is possible that the use of broad-spectrum antibiotics confers penicillin resistance more than 
the use of penicillin G only. A link between tetracycline resistance and β-lactamase 
production was reported (Waage et al., 2002). Exposure of S. aureus to one antibiotic may 
lead to acquisition of multiple resistance determinants by the strain since the determinants 
often co-exist in mobile genetic elements, which can transfer as entire elements from one 
strain to another in a single event. In the long run, multiresistance is considered to be a burden 
for microbes, including S. aureus, and continuous production of resistance factors confers no 
additional fitness in an environment where selection pressure from antimicrobials is low 
(Ala’Aldeen, 2002). Susceptibility can therefore be expected to return when the microbes are 
no longer exposed to the given antimicrobial.  
 
The entire normal microbiota of a dairy cow can be exposed to an antimicrobial during 
treatment. Frequent or long-term treatments cause selection pressure for resistant skin bacteria 
to develop (Gustafsson et al., 2003). The sites frequently supporting S. aureus can act as 
resistance reservoirs (IV). Susceptible strains may acquire resistance determinants 
(Yazdankhah et al., 2000) from this reservoir. The determinants such as blaZ can spread by 
mobile genetic elements including the penicillinase plasmid, where this gene often co-exists 
with sed and sej genes (Zhang et al., 1998). In most Finnish bovine S. aureus strains from 
mastitis the blaZ gene resides in a plasmid, whereas in Swedish strains the gene is mostly 
chromosomal (Bagcigil et al., unpublished data). In our studies (III-IV), blaZ was often 
present together with sed and sej, suggesting presence of the penicillinase plasmid, but as 
these genes were clustered in specific genetic lineages, horizontal spread of the putative 
plasmid in the study population was considered to have been uncommon (III-IV). This 
observation is in agreement with results from a recent Danish study, where horizontal spread 
of penicillin resistance was indicated to be a rare event (Olsen et al., 2006). This suggests that 
factors other than just penicillin resistance are involved in the selection of particular strains. 
 
Penicillin resistance was associated with particular herds in Norway (Østerås et al., 2006), but 
the number of herds or their proportion of all herds studied was not reported. High treatment 
incidence in those herds was suggested to be one reason for resistance, but dominance of 
specific, penicillin-resistant S. aureus strains caused by events other than selection pressure 
was also suggested by the authors. In the Finnish survey material, approximately half of the 
study herds harboured penicillin resistant S. aureus strains (I). Penicillin resistant strains can 
be distributed throughout the farm and can persist for long periods in the herd (IV). 
 
In many countries penicillin resistance limits the treatment options for S. aureus mastitis, and 
it can be considered to be a therapeutic problem. Several authors reported lower cure rates for 
mastitis caused by penicillin resistant S. aureus isolates compared with mastitis caused by 
penicillin susceptible isolates (Ziv and Storper, 1985; Sol et al., 2000; Taponen et al., 2003). 
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However, results from true comparison trials, where the same treatment protocol is used for 
both groups in a randomized, prospective study, are not available. Two retrospective studies 
(Sol et al., 1997; Sol et al., 2000) showed that therapy response was lower for mastitis due to 
β-lactamase producing S. aureus isolates than for mastitis caused by β-lactamase negative S. 
aureus, although both were treated with antibiotics from groups other than beta-lactams.  
 
In the survey material (I), MIC values for oxacillin in 4% of S. aureus isolates indicated 
resistance, but mecA was not detected (Pitkälä, A. et al., unpublished results). Similar results 
were reported from Norway and Sweden (NORM-VET; 2005 SVARM, 2005). No mecA 
positive isolates were found among any S. aureus isolates studied in this thesis. Oxacillin 
(methicillin) resistant strains may occur de novo by introduction of mecDNA into a 
susceptible strain (Cookson, 2000), or can be transferred from humans, in which MRSA is 
more common (Ferry and Etienne, 2007). Spread of such strains in milk of infected dairy 
cows represents a risk to public health (Juhász-Kaszanyitzky et al., 2007). The emphasis in 
Finland as in other countries should be in the prevention and control of mastitis caused by 
penicillin-resistant S. aureus, instead of broadening the selection of antimicrobials used for 
treatment. 
7.4. The role of strain characteristics in manifestation and persistence of Staphylococcus 
aureus IMI 
It is generally accepted that virulence of S. aureus originating from bovine mastitis can differ 
among strains. The limited diversity of strains causing most mastitis suggests that these 
strains are better adapted to infect the bovine mammary gland than are the sporadic strains 
(II). Some strains can rapidly become predominant in a particular herd and cause herd-wide 
mastitis outbreaks (Smith et al., 1998) or can persist in the same herds (Anderson and Lyman, 
2006) or in the same area for years (II). The variable therapy outcome within and between 
studies raises many questions, for which strain-associated virulence could be one answer (Sol 
et al., 2000; Taponen et al., 2005; Barkema et al., 2006). Some S. aureus strains, such as 
Newbould, have been shown to be completely unable to cause IMI or to cause only a very 
mild clinical response in experimental mastitis models (Schukken et al., 1999). 
 
Host response to a particular strain varies between individual cows and stage of lactation, 
making it complex to assess the severity of infection caused by particular S. aureus strains (II-
III).  Significant differences were still observed between pulsotypes in respect to severity of 
clinical signs and milk NAGase activity values which indicate inflammation in the quarter. 
Pulsotype C typically caused mild signs and the average milk NAGase activity values 
remained the lowest, whereas response of infection due to pulsotype B strains was 
significantly stronger, based on the severity of clinical signs and milk NAGase activity values 
(II). The number of other studies comparing host response in natural IMIs caused by different 
S. aureus strains is limited, but Zadoks et al. (2000) reported a similar association between 
clinical severity of mastitis and the PFGE type of the S. aureus strain causing the mastitis. 
Middleton et al. (2002a) used quarter milk SCC and NAGase activity values to study 
associations between inflammatory responses and PFGE strain-types derived from 191 cows 
with S. aureus IMI in eight herds. Using stringent strain definition criteria, the authors 
established no significant differences between strains for the inflammatory parameters and 
they concluded that response depends more on the individual host than on the infectious S. 
aureus strain-type. Supportive findings came from a study where the authors experimentally 
infected cows with different S. aureus strains. In that study, some cows developed clinical 
mastitis whereas others did not develop IMI despite receiving similar doses of S. aureus 
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(Middleton, J. R., unpublished data in Middleton et al., 2002a). Recently Fournier et al. 
(2008) analysed virulence gene patterns and genotypes of S. aureus using PCR amplification 
of the 16S-23S rRNA intergenic spacer for S. aureus strains derived from field cases of 
mastitis. The authors found one genotype to be related to high contagiousness and increased 
pathogenicity whereas the other types caused only sporadic infections. 
 
The different staphylococcal virulence factors have been proposed to play a role in different 
stages of infection, although overlap exists (Projan and Novick, 1997). Factors such as 
MSCRAMMs may be more important during the colonisation phase compared with factors 
such as superantigens, which tend to be produced by S. aureus once the infection has 
established. Some studies indicate the absolute importance of factors such as FnBPs for the 
establishment of S. aureus infection, as double mutants defective for both of the genes (fnbB 
and fnbA) encoding FnBPs have been shown to be incapable of adherence in vitro (Greene et 
al., 1995). To the best of our knowledge, such S. aureus strains have not been detected in 
natural bovine IMIs. In vivo studies using a murine mastitis model suggested relative 
virulence for particular virulence factors like HLA, because HLA-production has been 
correlated with lethality, and non-productive strains have induced mastitis but not death 
(Bramley et al., 1989). However, the absolute and relative importance of different virulence 
factors for inducing S. aureus infection has not been demonstrated. Determining that would 
be a herculean task for a pathogen with tens of putative virulence factors and inordinate 
numbers of combinations. Unlike the rabies virus, for example, that must infect in order to 
propagate, S. aureus is not an inherently pathogenic microorganism. The roles of individual 
virulence factors have therefore been assumed to increase the fitness and survival of the 
microbe in different environments. 
 
Optimal global evaluation of the differences in virulence among S. aureus strains would 
require epidemiological collection of the strains, standard methods for strain-typing and 
essential clinical information. The majority of the studies have included only some types of 
IMI, mostly subclinical (Fueyo et al., 2005), or clinical data or information such as milk SCC 
are not available. Collection of relevant clinical data from naturally occurring S. aureus 
mastitis is demanding and early detection of infection is required for correct characterization 
of the disease severity. Subclinical mastitis easily becomes chronic before it is detected. A 
particular strain causing mostly subclinical IMI may be easily categorised as a cause of 
persistent mastitis. This may have occurred for pulsotype C strains in our study (II). 
 
One relevant approach to explain virulence differences among mastitis-causing S. aureus 
isolates would be comparison of virulence determinants between dominant and sporadic 
genetic lineages. Although the gene profiles of individual strains can vary greatly among 
lineages, they have been shown to be relatively stable within lineages (Lindsay et al., 2006). 
The most frequent S. aureus genotypes can be assumed to possess such determinants that 
enhance their transmissibility and survivality. The genes hla, hld, hlg, lukED (III-IV) and 
fnbA (IV) were carried by the majority of the isolates. Although these genes may play a 
central role in pathogenesis of bovine IMI, their presence may not predict strain-specific 
virulence. By contrast, the occurrence of the fnbB, lukM, sec, sed, sei-seo, seu and tst genes 
varied markedly among genotypes, some of them being overrepresented in the predominant 
genotypes, or in genotypes causing a particular type of mastitis. 
 
The enhanced colonisation ability of some strains can increase transmission and consequently 
result in predominance of a specific strain. For both herds studied for this thesis the fnbA and 
fnbB genes were frequent and usually co-existed in the predominant pulsotypes, but only fnbA 
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was present in the sporadic types (IV). In Herd II in particular, pulsotype D may have 
benefited from its possibly high potential for adherence and may have therefore become 
predominant (IV). Increased colonisation capacity in prevalent strains could occur at the 
expense of virulence (Lipsitch and Moxon, 1997), compared with less common or sporadic 
strains. We suggest this to be the case for the predominant pulsotype D in Herd II, which 
carried both fnbA and fnbB but which lacked certain common virulence genes such as hlb, and 
generally had fewer virulence genes than several other types present in that herd (IV). 
 
The hlb gene was not identified as often as the other haemolysin genes in S. aureus strains 
derived from cases of mastitis (III). It typically co-existed with hla and other haemolysins in 
pulsotype B strains that were associated with more severe mastitis (III). Concomitant 
expression of HLA and HLB is considered to promote mutual effects (Dinges, 2000), when 
the response can be assumed to be stronger. hlb was less common in isolates from subclinical 
mastitis and was absent from pulsotype C strains in particular, which typically caused 
subclinical infection (III). In a previous study (Fueyo et al., 2005), hlb was slightly less 
frequent than other haemolysins and absent from specific S. aureus PFGE types. In contrast, 
Aarestrup et al. (1999) reported presence of hlb and HLB production to be more common than 
hla presence and HLA production in Danish bovine mastitis isolates, and hlb and its 
expression were more frequent among bovine than among human isolates. The data for the 
mastitis isolates, whether more clinical than subclinical, were not presented. One can also 
speculate that the hlb negative strains evolved from strains of human origin. From studies of 
human strains it is known that integration of certain bacteriophages into β-hemolysin 
inactivates the toxin (Coleman et al., 1991), when hlb could also remain undetected by PCR. 
These easily transmissible phages, named β-hemolysin (hlb)-converting bacteriophages, 
possess a group of genes termed the immune evasion cluster (IEC), where sea can co-exist 
with the genes of the newly discovered immune modulators, chemotaxis inhibitory protein of 
S. aureus (CHIPS), staphylococcal complement inhibitor (SCIN) (Rooijakkers et al., 2005), 
and staphylokinase (SAK) gene (van Wamel et al., 2006). In our study, strains from the hlb 
negative pulsotype C carried sea (III). 
 
Virulence determinants such as sec, tst and lukM that have been thought to cause a strong 
inflammatory response, were unique to or overrepresented in pulsotype B (III). TSST-1 is one 
of the few staphylococcal toxins where direct causality between toxin production and specific 
disease, toxic shock syndrome, has been demonstrated (Dinges et al., 2000). tst has been 
documented to be more prevalent in bovine than in human S. aureus strains (van Leeuwen et 
al., 2005). Production of SEC and TSST-1 was connected with severe clinical mastitis 
unresponsive to therapy (Jones and Wieneke, 1986), or with peracute mastitis in particular 
(Matsunaga et al., 1993). In Norway, 45% of S. aureus isolates from acute, chronic and 
subclinical bovine mastitis expressed SEC and TSST-1 and the isolates from acute clinical 
mastitis tended to more often produce enterotoxins and TSST-1 compared with isolates from 
subclinical and chronic mastitis (Tollersrud et al., 2000b). SEC was suggested to play a role in 
persistent bovine IMI, as stimulation by SEC caused inversion of the CD4+ T cell/ CD8+ T 
cell ratio (Ferens et al., 1998). The CD8+ T cell subpopulation down-regulated proliferation 
of CD4+ T cells, which can impair CD4+ T cell response to the pathogen (Park et al., 1993). 
Kuroishi et al. (2003) suggested SEC to be more important than TSST-1 in the pathogenesis 
of bovine IMI because intramammary inoculation by TSST-1, unlike SEC, was not associated 
with increase in milk SCC and severity of mastitis. Surprisingly, in the herds of study IV, tst 
and sec were detected in two sporadic genotypes that were not isolated from mastitis. 
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lukM was identified in approximately a quarter of the isolates from mastitis, but was clustered 
in pulsotype B strains, which typically caused clinical signs (III). LukM-production has been 
reported to be more common in clinical than in subclinical mastitis isolates (Schuberth et al., 
2001). lukM seems to co-exist more often in isolates carrying SAgs than in those lacking 
SAgs (Fueyo et al., 2005; studies III-IV). In three in vitro assays where biological activities of 
purified leukotoxins on bovine PMN cells were compared by measuring spreading on solid 
agar, Ca2+ influx and pore formation ability, the activities for lukM/lukF’-PV were highest 
(Barrio et al., 2006). Rainard et al. (2003) reported that supernatants from S. aureus isolates 
positive for lukM were more toxic to bovine PMN cells than supernatants from lukM negative 
isolates. Recently Rainard (2007) suggested that the toxin interferes in vivo with the 
neutrophil defence mechanism in ruminant IMI. Based on these reports, LukM can be 
supposed to be linked more with clinical than subclinical mastitis. As LukM seems to 
interfere with host defence and was linked to chronic mastitis among strains other than 
pulsotype B (III), it may be involved in persistent infection. 
 
Secreted SAgs are able to hamper host immune response and are therefore presumed to 
contribute to persistence of bovine IMI (Ferens and Bohach, 2000). Use of antimicrobials in 
the herds may promote persistence by stimulating toxin production of S. aureus. The presence 
of β-lactams and fluoroquinolones has been shown in vitro to stimulate HLA production 
(Ohlsen et al., 1998) and TSST-1 production (Dickgiesser and Wallach, 1987); the same can 
be expected to occur for other SAgs. 
 
The most predictive virulence genes for the persistence of IMI were sed and sej, which were 
overrepresented in isolates from persistent infections (III). The majority of the predominant, 
herd-wide disseminated S. aureus strains typically causing recurrent or chronic mastitis in 
Herd I had these genes (IV). The potential role of sed and sej in promoting development of 
persistent infection remains open to discussion. Only one study reported in vivo production 
and effects of SED during mastitis (Tollersrud et al., 2006). In that study, all 17 cows became 
infected and developed clinical mastitis after experimental intramammary infusion of SED-
producing S. aureus strain Mu60. SED was detected in mastitic milk, SED induced 
proliferation of bovine leukocytes in vitro, and anti-SED antibodies were elevated in serum. 
The sej gene, encoding SEJ, was identified in 1998 by Zhang et al. (Zhang et al., 1998). 
Superantigenic or emetic activity of the toxin remains to be demonstrated. SEJ is secreted 
during the exponential growth phase, whereas maximum production of SED is during 
transition from the exponential to stationary phase of bacterial growth (Zhang et al., 1998). If 
SEJ were superantigenic, SED and SEJ might have complementary effects on suppression of 
the host response. 
 
The benefit for mastitis-causing S. aureus to frequently carry egc is unclear. Although most of 
the egc-encoded toxins exhibit mitotic activity and can act as SAgs in conditions such as food 
poisoning, their importance has not yet been determined (Becker et al., 2004). Toxins coded 
for by egc have been associated with staphylococcal scarlet fever and toxic shock syndrome 
in humans (Jarraud et al., 1999), but have also been negatively correlated with the severity of 
infection (Ferry et al., 2005). The egc genes were demonstrated to accumulate more in 
carriage (nasal) strains than in invasive strains isolated from humans (van Belkum et al., 
2006). Antibodies are rarely produced against egc-encoded toxins (Holtfreter et al., 2004). It 
has been suggested that human nostrils tolerate the toxins encoded by egc and that this locus 
may increase the carriage potential of toxin-positive S. aureus (van Belkum et al., 2006). 
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The sea, seb, see, seh, sek, eta, and etb genes are absent or rare in bovine mastitis isolates 
(Larsen et al., 2000b; Akineden et al., 2001, Larsen et al., 2002; study III-IV). It can be 
concluded that these genes play a minor role in the dissemination and pathogenesis of bovine 
IMI. In contrast, sea has been associated with invasive S. aureus isolates in humans (Peacock 
et al., 2002). 
7.5 Reservoirs and transmission of Staphylococcus aureus 
The most important reservoir of S. aureus IMI is the infected mammary gland (Davidson et 
al., 1961; Roberson et al., 1998) in herds with S. aureus mastitis. The numbers of S. aureus 
secreted by the infected gland can be very high, exceeding millions of cfu/ml of milk 
(Kitchen, 1981). Prevalence of S. aureus IMI is considerably higher during lactation than 
during the dry period, suggesting that transmission of the pathogen occurs mostly via milk 
from infected quarters. In cases where heifers freshen with S. aureus (Roberson et al., 1994; 
study IV), multiparous cows develop S. aureus IMI during the dry period, or in herds, where 
S. aureus mastitis has been successfully controlled (Sommerhäuser et al., 2003), transmission 
mechanisms other than contact with infected milk are more likely. Extramammary sites and 
environment can form an important reservoir of S. aureus IMI, and the pathogen may survive 
in these sites despite control measures. 
 
Milking liners were demonstrated to be important vectors of mastitis-causing S. aureus strains 
(IV). This is in agreement with previous studies (Larsen et al., 2000a; Jørgensen et al., 2005a; 
Smith et al., 2005a). Transmission of S. aureus from the teat canals and skin of cows that did 
not have infected udder quarters to milking liners was apparent (IV). In Herd II, in 39 out of 
40 PFGE typed cases the liner contamination originated eg. from the skin of.quarters without 
S. aureus IMI (IV). The numbers of viable S. aureus transmitting from intact skin to milking 
liners can be expected to be lower than in the mastitic milk, but in damaged skin, the 
pathogen can be present in large numbers.  
 
S. aureus isolated from dairy herds has been suggested to form two distinguishable 
populations; those adapted to infect the mammary gland and those representing residents of 
extramammary sites (Fox et al., 1991; Zadoks et al., 2002; Smith et al., 2005b; Barkema et al., 
2006). Davidson et al. (1961) reported udders and teats to be the most important reservoirs for 
mastitis-causing S. aureus, but they also found phage types that persistently colonised these 
sites without causing IMI, suggesting strain-associated tissue adaptation. The authors also 
introduced one S. aureus strain into a group of cows and demonstrated the transmission of the 
strain to the cows, causing skin colonisation and IMI. Subsequently, many studies have 
reported mastitis-causing strains to be mostly different from those isolated from udder and 
teat skin (Fox et al., 1991; Zadoks et al., 2002; Smith et al., 2005b), but these findings do not 
apply to all herds, as shown by our results (IV) and other studies (Middleton et al., 2002b; 
Jørgensen et al., 2005a). These contradicotry findings may depend on factors like the size and 
management of the herd, and sampling criteria used in the study. 
 
Milk from an infected quarter is considered the primary source of mastitis-causing S. aureus. 
Sites in frequent contact with milk, such as teat canals, teat skin and milking liners can be 
expected to be contaminated with strains originating from the milk (Jørgensen et al., 2005a; 
study IV). As entry of S. aureus to the mammary gland is considered to occur via the teat 
canal (Anderson, 1983), preceded by teat skin and teat orifice colonisation by the bacteria 
(Bramley et al., 1979), mastitis-causing S. aureus strains can be expected to be found from 
these sites prior to IMI. This was directly demonstrated in two of the cows in Herd II, where 
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the same genotype that infected the udder quarter was also isolated from the teat skin prior to 
IMI (IV). 
 
Preparturient heifers can have their udders or colostrum colonised by the same S. aureus 
strains which cause the majority of IMIs in a herd (Middleton et al., 2002b; study IV), 
indicating that heifers can function as important reservoirs of S. aureus IMI. In a study by 
Roberson et al. (1994), almost one-third of new cases of S. aureus IMI in lactating herds were 
due to heifers that freshened with S. aureus IMI. Isolation of a heifer calf from S. aureus may 
be impossible as the microbe may transmit due to exposure to vaginal S. aureus during 
parturition, or possibly via uterine S. aureus infection (Davidson et al., 1961; Eduvie et al., 
1984). The strains in heifers that have been raised in the same herd are likely to be similar or 
genetically related to strains in adult cows, as shown in our study (IV).  
 
Preparturient S. aureus colonisation may predispose heifers to S. aureus mastitis after calving 
(Nickerson et al., 1995). The risk for S. aureus IMI developing at calving in heifers with S. 
aureus colonisation of the udder area was shown to be 3.4 times as high as in S. aureus-
negative heifers (Roberson et al., 1994). The prevalence of heifer mastitis caused by S. aureus 
varies geographically. In Norway S. aureus was the most common cause (approximately 46% 
of the isolated bacteria) of clinical mastitis of heifers within two weeks of calving (Waage et 
al., 1999). In a Danish study, prevalence of S. aureus mastitis in heifers was 1% at parturition, 
but increased almost up to 10% during the first month after calving (Aarestrup and Jensen, 
1997), indicating that heifers became infected after introduction to milking. 
 
In this study, hands and the nostrils of farm personnel harboured S. aureus strains that caused 
bovine IMI. Such findings agree with results of several previous studies (Fox et al., 1995; 
Roberson et al., 1998; Larsen et al., 2000a; Jørgensen et al., 2005a). Mastitis-derived bovine 
strains of S. aureus have been shown to be genetically distant from those causing human 
infections (van Leeuwen et al., 2005; Hata et al., 2008), but individuals, including farm 
personnel in close contact with animals, can be expected to share the same strains at least 
temporarily. Human hands can at least act as vectors, but their significance as long-term 
reservoirs was not the subject of this study. Variation within and between S. aureus clonal 
lineages originating from different host animals seems to be high (van Leeuwen et al., 2005; 
Herron-Olson et al., 2007; Ben Zakour et al., 2008; Sung et al., 2008), but strains from bovine 
S. aureus mastitis appear to carry several unique genes, which may be involved in adaptation 
of S. aureus to bovine udder. Some other genes such as bap involved in biofilm formation or 
gene complexes like "immune evasion cluster" may be less important for IMI, as these genes, 
in contrast to human isolates, are rare in bovine isolates (Monecke et al., 2007; Sung et al., 
2008). 
7.6 Future considerations for control of S. aureus mastitis 
The significance of S. aureus as a cause of mastitis differs among herds, suggesting a herd-
level approach. As a whole, most mastitis-causing S. aureus comprise a limited number of 
clones. However, the number and diversity of infecting S. aureus strains in a particular herd is 
affected by numerous factors, including the number of reservoirs, routes of transmission, and 
features that create selection pressure, such as treatment incidences etc. Some clinically 
important bacterial characteristics such as penicillin resistance appear to vary among isolates 
within identical clonal types. Clinical consequences can be different for the clonal variants 
and different mastitis control measures may be required. This suggests that antimicrobial 
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resistance and perhaps certain virulence properties of S. aureus should be tested in addition to 
molecular typing.  
 
Molecular typing can be used to formulate strategies for control of S. aureus mastitis, by 
identifying the reservoirs and fomites of mastitis-causing S. aureus in a herd. If the diversity 
of S. aureus strains has been determined for a herd, the information can be used to predict 
characteristics of the future S. aureus isolates in the same herd. Grinberg et al. (2005) applied 
information on penicillin-resistance status and genotypes of S. aureus isolates in a herd to 
predict the resistance status of subsequent isolates on the same farm, supposing the IMIs to be 
due to genetically related strains. 
 
Early detection of S. aureus IMI is critical to limit exposure time of the other quarters of the 
same cow and other cows to the pathogen, and to achieve satisfactory therapy responses for 
the cows to be treated. For that purpose, the threshold level for detection of mastitis using 
CMT (> 300 000/ml), as introduced 30 years ago by Klastrup and Schmidt Madsen (1974), is 
too high to detect IMI. Not more than about half the quarters with S. aureus IMI in the survey 
material had milk SCC over this threshold (I). In a more recent study, the SCC of healthy 
quarters was usually below 50 000 cells/ml (Barkema et al., 1999). Detection of mastitis 
represents a special challenge in herds milked using automatic systems. These herds are 
usually large and are loose-housed, where control, eradication and prevention of S. aureus can 
be difficult. The ability of an automatic milking system to detect mastitis has not been 
satisfactory (Hovinen et al., 2006), and teat-cleaning and disinfection of milking units 
between milkings may be inadequate (Hovinen et al. 2005). 
 
As milking liners appear to play a central role in transmission of S. aureus, cleaning of 
milking clusters and liners by backflushing or dipping in disinfectant (followed by thorough 
rinsing of the liners) has been proposed to eliminate S. aureus from the liners (IDF, 2006). 
However, S. aureus strains can survive in the liners despite standard post-milking washing 
procedures (IV). Post-milking teat disinfection, by dipping or spraying, is regarded as the 
single most important and probably the most effective mastitis control procedure (IDF, 2006). 
The large numbers of S. aureus on the teat skin despite post-milking teat-dipping suggests 
that either the dipping does not kill the bacteria or the bacteria are reintroduced from an 
unknown source. Whist et al. (2006) demonstrated under field conditions that efficacy of teat 
dips may not be as good as suggested, mainly based on the results of experimental challenge 
studies. 
 
In the light of the present and earlier studies, the prevalence and incidence of S. aureus 
mastitis can be successfully controlled, but total eradication of S. aureus from a herd may not 
be realistic. Control programmes should include measures to identify animals at risk to S. 
aureus IMI and those that enhance the host response. Genetic characteristics of individual 
cows have been shown to contribute to susceptibility of S. aureus mastitis (Schukken et al., 
1994), when host response can be improved via testing and selection of cows. Continuous 
monitoring of teat condition is required, as traumatised or abraded teats are likely to support 
S. aureus growth (Zadoks et al., 2001). The role of cows with traumatised or callused teats as 
S. aureus carriers should be studied. 
 
Recent studies on development of vaccines against S. aureus have focused on developing 
antibodies against specific virulence factors. The ideal factors would be those involved in the 
adhesion of S. aureus, since many of the genes encode these factors, e.g. fnbA is present in 
most strains. In experimental models, administration of vaccines to MSCRAMMs has 
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conferred broad, albeit not complete, protection against S. aureus IMIs (Brouillette et al., 
2002; Carter and Kerr, 2003). Another approach would be to develop strategies to prevent 
adherence of S. aureus by specifically blocking the interaction of the pathogen with 
fibronectin by antagonist ligands, as suggested by Arciola et al. (2005). 
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8. CONCLUSIONS 
1. During the past decade, mastitis control measures in Finland have contributed to 
reduction of mastitis prevalence. The relative proportion of S. aureus positive milk 
samples has diminished from 17 % in 1995 to 11 % in 2001, but the prevalence of 
cows infected by S. aureus has remained nearly stable, about 10 %, with 1.3 quarters 
infected by S. aureus per cow. S. aureus is present in two-thirds of the Finnish dairy 
herds. The significance of this pathogen differs in the herds, and a herd-level approach 
is needed for control of S. aureus mastitis. Thorough comparison between herds 
positive and negative for S. aureus would be helpful to explore herd-level factors 
exposing to S. aureus mastitis. In the two study herds with problems of S. aureus 
mastitis, in average 48% of quarters and 85% of cows harboured S. aureus on the teat 
skin or in the teat canal, indicating the wide spread of the bacterium in these herds. 
 
2. S. aureus isolates collected during 1993-1997 can be divided into five predominant 
and 17 sporadic genotypes. The diversity of S. aureus genotypes appears to be wide, 
but a limited number of types predominate as mastitis-causing agents. Isolates 
belonging to certain genotypes were detected during several years in the same herds or 
in the same area. To find out if these isolates share the same ancestor or 
epidemiological origin would require typing by MLST. The factors encoding 
haemolysins and leukocidin ED were the most common virulence factors, carried by 
the majority of S. aureus isolates. Horizontal transfer may be common for egc-
encoded superantigens as these were found from several different PFGE types. The 
genes for other superantigens were PFGE type linked. 
 
3. S. aureus penicillin resistance is very common and widely distributed in Finnish herds. 
The blaZ gene coding for penicillin resistance seems to be often linked to sed and sej 
enterotoxin genes, which could indicate the presence of a penicillinase plasmid in 
those strains. These genes were present only in certain predominating PFGE types. 
This may indicate that horizontal spread of the putative penicillinase plasmid has not 
been common. Resistance to other antimicrobials was limited and no methicillin 
resistant isolates were found. 
 
4. On the basis of severity of clinical signs and milk NAGase activity, virulence of S. 
aureus differs between strains. Strains carrying particularly genes sed, sej, and blaZ 
were associated with persistent mastitis. One pulsotype causing mild to severe clinical 
mastitis instead of subclinical mastitis was elimiminated from the udder almost 
always. 
 
5. The same S. aureus strains which caused intramammary infections were also detected 
from the extramammary sites. The same strains frequently resided on healthy teat skin 
and in teat canals of cows free from intramammary infection. These sites can act as 
reservoirs of mastitis causing S. aureus, as well as wounds and skin lesions of the 
cows. Hands of the farm personnel can at least temporarily be contaminated with the 
same strains. Predominant S. aureus strains had the adhesion determinants fnbA and 
fnbB more often than the sporadic strains, which may have contributed to the better 
survival and spread of these strains in the herds. The diversity of S. aureus pulsotypes 
was higher in the herd which purchased cattle as compared with the closed herd. 
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6. Information on the ecology, epidemiology and characteristics of S. aureus presented in 
this thesis may be useful for planning control strategies in herds with problems of S. 
aureus mastitis. Diagnosis to strain level and determination of certain virulence 
determinants would be necessary to target measures against infections caused by 
specific strains. This would require molecular techniques feasible also for field use. 
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